FORM 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 001-34594

 

 

TOWERS WATSON & CO.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   27-0676603

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

875 Third Avenue

New York, NY

  10022
(Address of principal executive offices)   (zip code)

(212) 725-7550

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer” and “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of April 30, 2013, there were 65,190,459 outstanding shares of Class A Common Stock at a par value of $0.01 per share, and 5,374,070 outstanding shares of Class B-4 Common Stock at a par value of $0.01 per share.

 

 

 


Table of Contents

TOWERS WATSON & CO.

INDEX TO FORM 10-Q

For the Three and Nine Months Ended March 31, 2013

 

     Page  

PART I. FINANCIAL INFORMATION

  

Item 1. Financial Statements (Unaudited)

  

Condensed Consolidated Statements of Operations — Three and Nine Months Ended March  31, 2013 and 2012

     1   

Condensed Consolidated Statements of Comprehensive Income — Three and Nine Months Ended March  31, 2013 and 2012

     2   

Condensed Consolidated Balance Sheets — March 31, 2013 and June 30, 2012

     3   

Condensed Consolidated Statements of Cash Flows — Nine Months Ended March 31, 2013 and 2012

     4   

Condensed Consolidated Statement of Changes in Stockholders’ Equity — Nine Months Ended March 31, 2013

     5   

Notes to the Condensed Consolidated Financial Statements

     6   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     24   

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     40   

Item 4. Controls and Procedures

     41   

PART II. OTHER INFORMATION

  

Item 1. Legal Proceedings

     41   

Item 1A. Risk Factors

     41   

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     41   

Item 3. Defaults Upon Senior Securities

     42   

Item 4. Mine Safety Disclosures

     42   

Item 5. Other Information

     42   

Item 6. Exhibits

     43   

Signatures

     44   

Certifications

  


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

TOWERS WATSON & CO.

Condensed Consolidated Statements of Operations

(In thousands of U.S. dollars, except per share data)

(Unaudited)

 

     Three Months Ended
March 31,
    Nine Months Ended
March 31,
 
     2013     2012     2013     2012  

Revenue

   $ 940,967      $ 901,516      $ 2,721,461      $ 2,591,577   
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs of providing services:

        

Salaries and employee benefits

     564,368        544,599        1,657,806        1,577,375   

Professional and subcontracted services

     63,225        69,644        190,921        212,665   

Occupancy

     35,418        38,987        110,003        107,047   

General and administrative expenses

     82,273        79,263        251,963        214,359   

Depreciation and amortization

     43,777        38,729        133,049        111,884   

Transaction and integration expenses

     12,328        21,411        30,753        65,221   
  

 

 

   

 

 

   

 

 

   

 

 

 
     801,389        792,633        2,374,495        2,288,551   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     139,578        108,883        346,966        303,026   

Income (loss) from affiliates

     —          167        (56     335   

Interest income

     613        784        2,118        2,942   

Interest expense

     (3,483     (313     (10,043     (6,808

Other non-operating income

     12        724        5,060        8,870   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     136,720        110,245        344,045        308,365   

Provision for income taxes

     41,875        41,199        110,807        113,622   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income before non-controlling interests

     94,845        69,046        233,238        194,743   

Less: Net (loss) income attributable to non-controlling interests

     (71     812        (2,695     (134
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to controlling interests

   $ 94,916      $ 68,234      $ 235,933      $ 194,877   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per share:

        

Net income attributable to controlling interests — basic

   $ 1.35      $ 0.95      $ 3.32      $ 2.69   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to controlling interests — diluted

   $ 1.34      $ 0.95      $ 3.29      $ 2.68   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares of common stock, basic (000)

     70,530        71,624        71,094        72,377   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares of common stock, diluted (000)

     71,076        71,953        71,639        72,658   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial statements

 

1


Table of Contents

TOWERS WATSON & CO.

Condensed Consolidated Statements of Comprehensive Income

(In thousands of U.S. dollars)

(Unaudited)

 

     Three Months Ended
March 31,
    Nine Months Ended
March 31,
 
     2013     2012     2013     2012  

Net income before non-controlling interests

   $ 94,845      $ 69,046      $ 233,238      $ 194,743   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss)/income, net of tax:

        

Foreign currency translation

     (96,135     38,260        (47,412     (48,486

Defined pension and post-retirement benefit costs

     (4,137     3,320        (21,260     10,745   

Hedge effectiveness

     546        14        (250     (452

Available-for-sale securities

     93        (105     149        (712
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss)/income before non-controlling interests

     (99,633     41,489        (68,773     (38,905

Comprehensive (loss)/income before non-controlling interests

     (4,788     110,535        164,465        155,838   

Comprehensive (loss)/income attributable to non-controlling interest

     (1,316     1,535        (3,072     145   
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss)/income attributable to controlling interests

     (3,472     109,000        167,537        155,693   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial statements

 

2


Table of Contents

TOWERS WATSON & CO.

Condensed Consolidated Balance Sheets

(In thousands of U.S. dollars, except share data)

(Unaudited)

 

     March 31,
2013
    June 30,
2012
 

Assets

  

Cash and cash equivalents

   $ 472,691      $ 478,179   

Restricted cash

     178,335        171,406   

Short-term investments

     26,430        40,436   

Receivables from clients:

    

Billed, net of allowances of $16,267 and $20,871

     528,303        564,111   

Unbilled, at estimated net realizable value

     341,245        320,240   
  

 

 

   

 

 

 
     869,548        884,351   

Other current assets

     167,973        185,025   
  

 

 

   

 

 

 

Total current assets

     1,714,977        1,759,397   

Fixed assets, net

     351,965        315,000   

Deferred income taxes

     135,881        157,491   

Goodwill

     2,236,602        2,252,555   

Intangible assets, net

     704,155        768,848   

Other assets

     122,766        103,687   
  

 

 

   

 

 

 

Total Assets

   $ 5,266,346      $ 5,356,978   
  

 

 

   

 

 

 

Liabilities

    

Accounts payable, accrued liabilities and deferred income

   $ 319,381      $ 333,443   

Employee-related liabilities

     521,291        558,222   

Fiduciary liabilities

     178,335        171,406   

Term loan — current

     18,750        —      

Other current liabilities

     55,730        39,911   
  

 

 

   

 

 

 

Total current liabilities

     1,093,487        1,102,982   

Revolving credit facility

     135,000        208,000   

Term loan

     231,250        250,000   

Accrued retirement benefits and other employee-related liabilities

     819,957        880,877   

Professional liability claims reserve

     261,186        266,619   

Other noncurrent liabilities

     191,261        191,183   
  

 

 

   

 

 

 

Total Liabilities

     2,732,141        2,899,661   
  

 

 

   

 

 

 

Commitments and contingencies

    

Stockholders’ Equity

    

Class A Common Stock — $0.01 par value: 300,000,000 shares authorized; 68,665,019 and 63,521,654 issued and 65,174,625 and 60,666,474 outstanding

     687        635   

Class B Common Stock — $0.01 par value: 93,500,000 shares authorized; 5,374,070 and 11,035,878 issued and 5,374,070 and 11,035,878 outstanding

     54        110   

Additional paid-in capital

     1,821,872        1,833,799   

Treasury stock, at cost — 3,490,394 and 2,855,180 shares

     (202,524     (168,901

Retained earnings

     1,311,532        1,117,622   

Accumulated other comprehensive loss

     (419,141     (350,745
  

 

 

   

 

 

 

Total Stockholders’ Equity

     2,512,480        2,432,520   
  

 

 

   

 

 

 

Non-controlling interest

     21,725        24,797   
  

 

 

   

 

 

 

Total Equity

     2,534,205        2,457,317   
  

 

 

   

 

 

 

Total Liabilities and Total Equity

   $ 5,266,346      $ 5,356,978   
  

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial statements

 

3


Table of Contents

TOWERS WATSON & CO.

Condensed Consolidated Statements of Cash Flows

(In thousands of U.S. dollars)

(Unaudited)

 

     Nine Months Ended
March 31,
 
     2013     2012  

Cash flows from operating activities:

    

Net income before non-controlling interests

   $ 233,238      $ 194,743   

Adjustments to reconcile net income to net cash from operating activities:

    

Provision for doubtful receivables from clients

     8,204        9,009   

Depreciation

     73,762        63,491   

Amortization of intangible assets

     59,287        48,393   

Provision for deferred income taxes

     39,120        63,878   

Equity from affiliates

     —          212   

Stock-based compensation

     24,203        45,590   

Other, net

     (2,333     5,561   

Changes in operating assets and liabilities (net of business acquisitions)

    

Receivables from clients

     112        (150,995

Restricted cash

     (6,796     (27,558

Other current assets

     (10,053     (6,542

Other noncurrent assets

     1,260        (28,353

Accounts payable, accrued liabilities and deferred income

     (8,706     42,796   

Employee-related liabilities

     (40,326     (50,810

Fiduciary liabilities

     6,796        32,634   

Accrued retirement benefits and other employee-related liabilities

     (118,029     (33,731

Professional liability claims reserves

     (4,997     (54,270

Other current liabilities

     (223     1,325   

Other noncurrent liabilities

     1,508        1,360   

Income tax related accounts

     30,484        1,776   
  

 

 

   

 

 

 

Cash flows from operating activities

   $ 286,511      $ 158,509   
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Cash paid for business acquisitions

     (5,678     (3,012

Cash acquired from business acquisitions

     636        2,101   

Fixed assets and software for internal use

     (66,626     (91,258

Capitalized software costs

     (41,768     (18,701

Purchases of available-for-sale securities

     (18,188     —     

Redemption of available-for-sale securities

     36,258        59,479   

Proceeds from divestitures

     4,285        1,606   
  

 

 

   

 

 

 

Cash flows used in investing activities

   $ (91,081   $ (49,785
  

 

 

   

 

 

 

Cash flows used in financing activities:

    

Borrowings under credit facility

     391,600        251,000   

Repayments under credit facility

     (464,600     (188,000

Repayments of notes payable

     —          (100,771

Dividends paid

     (48,147     (19,378

Repurchases of common stock

     (41,596     (100,789

Payroll tax payments on vested shares

     (24,879     (33,183

Issuances of common stock and excess tax benefit

     —          3,333   
  

 

 

   

 

 

 

Cash flows used in financing activities

   $ (187,622   $ (187,788
  

 

 

   

 

 

 

Effect of exchange rates on cash

   $ (13,296   $ (22,685
  

 

 

   

 

 

 

Decrease in cash and cash equivalents

     (5,488     (101,749

Cash and cash equivalents at beginning of period

     478,179        528,923   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 472,691      $ 427,174   
  

 

 

   

 

 

 

Supplemental disclosures:

    

Cash paid for interest

   $ 6,278      $ 4,625   
  

 

 

   

 

 

 

Cash paid for income taxes, net of refunds

   $ 43,398      $ 47,900   
  

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial statements

 

4


Table of Contents

TOWERS WATSON & CO.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

(In thousands of U.S. Dollars and numbers of shares in thousands)

(Unaudited)

 

    Class A
Common
Stock
Outstanding
    Class A
Common
Stock
    Class B
Common
Stock
Outstanding
    Class B
Common
Stock
    Additional
Paid-in
Capital
    Treasury
Stock, at
Cost
    Retained
Earnings
    Accumulated
Other
Comprehensive
Loss
    Non-
Controlling
Interest
    Total  

Balance as of June 30, 2012

    63,522      $ 635        11,036      $ 110      $ 1,833,799      $ (168,901   $ 1,117,622      $ (350,745   $ 24,797      $ 2,457,317   

Net income/(loss)

    —          —          —          —          —          —          235,933        —          (2,695     233,238   

Other comprehensive income

    —          —          —          —          —          —          —          (68,396     (377     (68,773

Repurchases of common stock

    —          —          —          —          —          (46,618     —            —          (46,618

Shares received for employee taxes upon conversion of Restricted A shares

    (429     (4     —          —          —          (24,875     —          —          —          (24,879

Exercises of stock options

    —          —          —          —          (5,560     6,378        —          —          —          818   

Restricted stock unit vesting

    (89     —          —          —          (30,570     31,492        —          —          —          922   

Class A Common Stock:

                   

Cash dividends declared

    —          —          —          —          —          —          (42,023     —          —          (42,023

Stock-based compensation

    —          —          —          —          24,203        —          —          —          —          24,203   

Acceleration of Class B shares to Class A shares

    5,661        56        (5,662     (56     —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of March 31, 2013

    68,665      $ 687        5,374      $ 54      $ 1,821,872      $ (202,524   $ 1,311,532      $ (419,141   $ 21,725      $ 2,534,205   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial statements

 

5


Table of Contents

TOWERS WATSON & CO.

Notes to the Condensed Consolidated Financial Statements

(Tabular amounts are in thousands, except per share data)

(Unaudited)

Note 1 — Organization and Basis of Presentation.

The accompanying unaudited quarterly condensed consolidated financial statements of Towers Watson & Co. (“Towers Watson”, the “Company” or “we”) and our subsidiaries are presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and therefore do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”). In the opinion of management, these condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial statements and results for the interim periods. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read together with the Towers Watson audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, which was filed with the SEC on August 29, 2012, and may be accessed via EDGAR on the SEC’s web site at www.sec.gov. Balance sheet data as of June 30, 2012 was derived from Towers Watson’s audited financial statements.

Towers Watson was formed on January 1, 2010, upon the merger (the “Merger”) of Watson Wyatt Worldwide, Inc. (“Watson Wyatt”) and Towers, Perrin, Forster & Crosby, Inc. (“Towers Perrin”).

Our fiscal year 2013 began July 1, 2012 and ends June 30, 2013.

The results of operations for the three and nine months ended March 31, 2013 are not necessarily indicative of the results that can be expected for the entire fiscal year ending June 30, 2013. The results reflect certain estimates and assumptions made by management including those estimates used in calculating acquisition consideration and fair value of tangible and intangible assets and liabilities, estimated bonuses and anticipated tax liabilities that affect the amounts reported in the condensed consolidated financial statements and related notes.

Note 2 — Acquisitions.

During the fourth quarter of the fiscal year ended June 30, 2012, we completed the acquisition of Extend Health, Inc. (“Extend Health”). This acquisition was not material for the purposes of financial statement disclosures as required by Accounting Standards Codification (“ASC”) 805. The following summary is included to provide our investors with a better understanding of this recent strategic acquisition.

Extend Health Acquisition

On May 29, 2012, Towers Watson purchased Extend Health, a leading provider of health benefit management services and operator of the largest private Medicare exchange, for $435 million in cash and assumed stock options valued at $11.2 million. See Note 12 for further information on the assumed stock options. This acquisition enables Towers Watson to provide employers with health care solutions that combine specialized retiree medical transition consulting with the choice and cost advantages of individual Medicare plans purchased on a private exchange. Extend Health now operates as a business segment called Exchange Solutions, alongside the existing segments of Benefits, Talent and Rewards, and Risk and Financial Services. We include the results of Extend Health’s operations since its acquisition date in the Exchange Solutions segment and in our condensed consolidated financial statements.

During the fourth quarter of fiscal 2012, we recorded the tangible assets received, liabilities assumed and the preliminary fair value of intangibles as follows: $123.2 million of customer related intangibles, $26.7 million of developed technology, and less than $1.0 million of favorable lease agreements and trade name intangibles. Our estimate of fair value was developed using income approach valuation models such as the multi-period excess earnings method for the customer-related intangibles and the relief from royalty method for the developed technology intangible. Significant assumptions used in the valuation were revenue growth rates, retention rates, expense and contributory asset charges, royalty rates and discount rates. We recorded current income tax receivables of $2.7 million for tax losses to be carried back to the June 30, 2011 U.S. federal income tax return. Also related to taxes, we recorded net deferred tax liabilities of $53.8 million. In accordance with acquisition accounting under U.S. GAAP, we will not realize $14.6 million of deferred revenue associated with cash received for commissions paid by carriers for policies placed prior to the acquisition and for which no subsequent performance obligation is required. We determined that total consideration was $446.2 million, and recorded $341.5 million of goodwill related to the acquisition of Extend Health. The acquisition accounting was finalized during the second quarter of fiscal 2013.

 

6


Table of Contents

Note 3 — Fixed Income Securities.

We hold available-for-sale fixed income securities comprised of U.S. treasury securities and obligations of the U.S. government, government agencies and authorities; corporate bonds; foreign corporate bonds; and obligations of states, municipalities and political subdivisions. The fixed income securities are classified either as short-term investments or non-current assets (within other assets on the condensed consolidated balance sheet) depending on the date of their maturity. Additional information on fixed income security balances is provided in the following table as of March 31, 2013 and June 30, 2012:

 

     March 31, 2013      June 30, 2012  
     Amortized
Cost
     Unrealized
Gains
     Unrealized
Losses
    Estimated
Fair Value
     Amortized
Cost
     Unrealized
Gains
     Unrealized
Losses
    Estimated
Fair Value
 

Short-term investments:

   $ 26,397       $ 20       $ (3   $ 26,414       $ 40,213       $ 218       $ (10   $ 40,421   

Other assets:

                     

(non-current)

     —           —           —          —           11,924         24         (19     11,929   

Proceeds from sales and maturities of investments for available-for-sale fixed income securities during the nine months ended March 31, 2013 were $34.7 million, resulting in no realized gains/losses, and during the nine months ended March 31, 2012 were $59.5 million, resulting in a realized gain of $0.1 million. There were no investments that have been in a continuous loss position for more than twelve months, and there have been no other-than-temporary impairments recognized.

Note 4 — Goodwill and Intangible Assets.

The following table reflects goodwill by segment as well as changes in those balances for the nine months ended March 31, 2013:

 

     Benefits     Risk and
Financial
Services
    Talent and
Rewards
    Exchange
Solutions
     All Other      Total  

Balance as of June 30, 2012

   $ 1,253,255      $ 545,862      $ 111,212      $ 341,012       $ 1,214       $ 2,252,555   

Goodwill acquired

     —          5,897        —          453         —           6,350   

Translation adjustment

     (13,201     (7,827     (1,275     —           —           (22,303
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Balance as of March 31, 2013

   $ 1,240,054      $ 543,932      $ 109,937      $ 341,465       $ 1,214       $ 2,236,602   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Included in the Risk and Financial Services goodwill acquired is $5.3 million of goodwill related to the acquisition of Oxford Investment Partners, which closed on February 1, 2013.

The following table reflects changes in the net carrying amount of the components of finite-lived intangible assets for the nine months ended March 31, 2013:

 

     Customer
related
intangible
    Core/
developed
technology
    Favorable
lease
agreements
    Total  

Balance as of June 30, 2012

   $ 289,521      $ 103,289      $ 4,554      $ 397,364   

Amortization

     (33,702     (25,585     (730     (60,017

Translation adjustment

     (1,171     (360     —          (1,531
  

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of March 31, 2013

   $ 254,648      $ 77,344      $ 3,824      $ 335,816   
  

 

 

   

 

 

   

 

 

   

 

 

 

For the three and nine months ended March 31, 2013, we recorded $19.4 million and $59.3 million, respectively, of amortization related to our intangible assets, exclusive of favorable lease agreements. For the three and nine months ended March 31, 2012, we recorded $17.7 million and $48.4 million of amortization related to our intangible assets.

As part of the integration of our Retirement business, during the second quarter of fiscal 2012, management decided to discontinue the use of an application that was acquired in the Merger with an expected useful life of ten years. We calculated no impairment associated with this application and we shortened the life of the intangible asset and accelerated the amortization in the same pattern in which our clients are transitioned to the surviving application, which is expected to occur predominantly over the next two to three years. To develop our estimated useful remaining life of the application, we are using client engagement revenue and the planned transition developed by our business management. As a result, we recorded an additional $0.9 million and $4.7 million of amortization for the three and nine months ended March 31, 2013, respectively, and an additional $3.8 million and $6.3 million of amortization for the three and nine months ended March 31, 2012, respectively.

 

7


Table of Contents

Our indefinite-lived non-amortizable intangible assets consist of acquired trademarks and trade names. The carrying value of these assets was $368.3 million and $371.4 million as of March 31, 2013 and June 30, 2012, respectively. The change during the period was due to foreign currency translation.

Our acquired unfavorable lease liabilities were $14.3 million and $17.0 million as of March 31, 2013 and June 30, 2012, respectively, and are recorded in the other noncurrent liabilities in the condensed consolidated balance sheet. The change for the nine months ended March 31, 2013 was comprised of a reduction to rent expense of $2.7 million.

The following table reflects the carrying value of finite-lived intangible assets and liabilities as of March 31, 2013 and June 30, 2012:

 

     As of March 31, 2013      As of June 30, 2012  
     Gross
Carrying
Amount
     Accumulated
Amortization
     Gross
Carrying
Amount
     Accumulated
Amortization
 

Finite-lived intangible assets and liabilities:

           

Trademark and trade name

     370         370         370         370   

Customer related intangibles

     387,561         132,913         390,264         100,743   

Core/developed technology

     165,181         87,837         173,498         70,209   

Favorable lease agreements

     6,610         2,786         6,625         2,071   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total finite-lived intangible assets

   $ 559,722       $ 223,906       $ 570,757       $ 173,393   
  

 

 

    

 

 

    

 

 

    

 

 

 

Unfavorable lease agreements

     25,602         11,293         27,670         10,707   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total finite-lived intangible liabilities

   $ 25,602       $ 11,293       $ 27,670       $ 10,707   
  

 

 

    

 

 

    

 

 

    

 

 

 

Certain trademark and trade-name intangible assets have indefinite useful lives and are not amortized. The weighted average remaining life of amortizable intangible assets and liabilities at March 31, 2013 was 6.2 years.

The following table reflects:

1) future estimated amortization expense for amortizable intangible assets consisting of customer related intangibles and core/developed technology, and

2) the rent offset resulting from the amortization of the net lease intangible assets and liabilities for the remainder of fiscal 2013 and for subsequent fiscal years:

 

Fiscal year ending June 30,

   Amortization      Rent Offset  

2013

   $ 17,783       $ (596

2014

     66,649         (2,313

2015

     60,884         (2,002

2016

     54,421         (1,557

2017

     49,067         (1,861

Thereafter

     83,188         (2,156
  

 

 

    

 

 

 

Total

   $ 331,992       $ (10,485
  

 

 

    

 

 

 

Note 5 — Fair Value Measurements.

We have categorized our financial instruments into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets and liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). In some cases, the inputs used to measure fair value might fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

Financial assets and liabilities recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs in the valuation techniques as follows:

Level 1 — Financial assets and liabilities whose values are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

Level 2 — Financial assets and liabilities whose values are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 — Financial assets and liabilities whose values are based on unobservable inputs for the asset or liability.

 

8


Table of Contents

The following presents our assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and June 30, 2012:

 

                                                   
     Fair Value Measurements on a Recurring Basis at
March 31, 2013
 
     Level 1      Level 2      Level 3      Total  

Assets:

           

Available-for-sale securities:

           

U.S. treasury securities and obligations of the U.S government, government agencies and authorities (a)

   $ 2,020       $ 1,501       $ —         $ 3,521   

Corporate bonds (a)

     —           20,064         —           20,064   

Foreign corporate bonds (a)

     —           2,829         —           2,829   

Equity securities (a)

     1,441         —           —           1,441   

Mutual funds / exchange traded funds (b)

     26,467         —           —           26,467   

Derivatives:

           

Foreign exchange forwards (c)

     —           295         —           295   

Liabilities:

           

Derivatives:

           

Foreign exchange forwards (c)

   $ —         $ 1,781       $ —         $ 1,781   

 

                                                   
     Fair Value Measurements on a Recurring Basis at
June 30, 2012
 
     Level 1      Level 2      Level 3      Total  

Assets:

           

Available-for-sale securities:

           

U.S. treasury securities and obligations of the U.S government, government agencies and authorities (a)

   $ 2,035       $ 9,085       $ —         $ 11,120   

Corporate bonds (a)

     —           32,494         —           32,494   

Foreign corporate bonds (a)

     —           3,501         —           3,501   

Obligations of states, municipalities and political subdivisions (a)

     —           5,234         —           5,234   

Equity securities (a)

     1,437         —           —           1,437   

Mutual funds (b)

       5,083         —           —           5,083   

Derivatives:

           

Foreign exchange forwards (c)

     —           713         —           713   

Liabilities:

           

Derivatives:

           

Foreign exchange forwards (c)

   $ —         $ 329       $ —         $ 329   

 

(a) These assets are included in short-term investments or other assets on the condensed consolidated balance sheet. See Note 3 for the classification of all fixed income securities as current or non-current.
(b) These assets are included in other assets on the condensed consolidated balance sheet.
(c) These derivative investments are included in other current assets or accounts payable, accrued liabilities and deferred income on the condensed consolidated balance sheet. See Note 6 for further information on our derivative investments.

We record gains or losses related to the changes in the fair value of our financial instruments for foreign exchange forward contracts accounted for as foreign currency hedges in general and administrative expenses in the condensed consolidated statements of operations. For the three and nine months ended March 31, 2013, we recorded a loss of $1.5 million and $1.5 million, respectively, for instruments still held at March 31, 2013. For the three and nine months ended March 31, 2012, we recorded a gain of $1.1 million and $1.1 million, respectively, for instruments still held at March 31, 2012. There were no material gains or losses recorded in the condensed consolidated statements of operations for available-for-sale securities still held at March 31, 2013 or 2012.

 

9


Table of Contents

To determine the fair value of our derivative positions, we use valuations from the counterparty of each hedge. This is a Level 2 valuation based on observable rates in the market. Counterparties use proprietary models to calculate values and are not actual quotes that could be used to terminate the contracts, but we believe the valuations are very close to the value of each contract if terminated since we review the valuations and compare these valuations against our own calculated fair value. We monitor the counterparty default risk both before the hedge is placed and prospectively throughout the life of the contract and would adjust fair values if asset impairment was deemed significant.

The U.S. Treasury securities, equity securities, exchange traded funds and mutual funds are valued using quoted market prices as of the end of the trading day. Corporate bonds and certain obligations of government agencies or states, municipalities and political subdivisions are valued based on yields currently available on comparable securities of issuers with similar credit ratings. We monitor the value of the investments for other-than-temporary impairment on a quarterly basis.

The availability of observable market data is monitored to assess the appropriate classification of financial instruments within the fair value hierarchy. Changes in economic conditions or model-based valuation techniques may require the transfer of financial instruments from one fair value level to another. In such instances, the transfer is reported at the beginning of the reporting period. There were no transfers between Levels 1, 2 or 3 during the three and nine months ended March 31, 2013.

Note 6 — Derivative Financial Instruments.

We are exposed to market risk from changes in foreign currency exchange rates. Where possible, we identify exposures in our business that can be offset internally. Where no natural offset is identified, we may choose to enter into various derivative transactions. These instruments have the effect of reducing our exposure to unfavorable changes in foreign currency rates. We do not enter into derivative transactions for trading purposes.

A number of our foreign subsidiaries receive revenues (through either internal or external billing) in currencies other than their functional currency. As a result, the foreign subsidiary’s functional currency revenue will fluctuate as the currency exchange rates change. To reduce this variability, we use foreign exchange forward contracts to hedge the foreign exchange risk of the forecasted collections. We have designated these derivatives as cash flow hedges of its forecasted foreign currency denominated collections. We also use derivative financial contracts, principally foreign exchange forward contracts, to hedge other non-functional currency obligations. These exposures primarily arise from intercompany lending and other liabilities denominated in foreign currencies. At March 31, 2013, the longest outstanding maturity was 10 months. As of March 31, 2013, a net $0.02 million pretax gain was deferred in accumulated other comprehensive income and is expected to be recognized in general and administrative expenses during the next 12 months when the hedged revenue is recognized. During the three and nine months ended March 31, 2013, we recognized no material gains or losses due to hedge ineffectiveness.

As of March 31, 2013 and June 30, 2012, we had cash flow and economic hedges with a notional value of $69.8 million and $66.4 million, respectively, to hedge internal and external revenue cash flows. We determine the fair value of our foreign currency derivatives based on quoted prices received from the counterparty for each contract, which we evaluate using pricing models whose inputs are observable. The net fair value of all derivatives held as of March 31, 2013 and June 30, 2012 was a liability of $1.5 million and an asset of $0.4 million, respectively. See Note 5, Fair Value Measurements, for further information regarding the determination of fair value.

The fair value of our derivative instruments held as of March 31, 2013 and June 30, 2012 and their location in the condensed consolidated balance sheet are as follows:

 

     Derivative assets      Derivative liabilities  
     Balance sheet location    Fair value      Balance sheet location    Fair value  
          March 31,
2013
     June 30,
2012
          March 31,
2013
    June 30,
2012
 

Derivatives designated as hedging instruments:

                

Foreign exchange forwards

   Other current assets    $ 268       $ 408       Other current liabilities    $ (245   $ —     

Derivatives not designated as hedging instruments:

                

Foreign exchange forwards

   Other current assets      27         305       Other current liabilities      (1,536     (329
     

 

 

    

 

 

       

 

 

   

 

 

 

Total derivative assets (liabilities)

      $ 295       $ 713          $ (1,781   $ (329
     

 

 

    

 

 

       

 

 

   

 

 

 

 

10


Table of Contents

The effects of derivative instruments that are designated as hedging instruments on the condensed consolidated statement of operations and the condensed consolidated statement of changes in stockholders’ equity for the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013 and 2012 are as follows:

 

Derivatives designated as
hedging instruments for the
three months ended March 31,
2013 and 2012:

   Gain
recognized in  OCI
(effective portion)
    Location
of (loss) gain reclassified
from OCI into income
(effective portion)
   (Loss) gain reclassified
from OCI into income
(effective  portion)
     Location of (loss) gain
recognized in income
(ineffective portion and
amount excluded from
effectiveness testing)
   (Loss) gain recognized
in income (ineffective
portion and
amount excluded from
effectiveness testing)
 
     2013     2012          2013     2012           2013     2012  

Foreign exchange forwards

   $  556      $  495      General and
administrative expenses
   $ (386   $ 469       General and
administrative expenses
   $ (1   $ 39   
  

 

 

   

 

 

      

 

 

   

 

 

       

 

 

   

 

 

 

Total

   $ 556      $ 495         $ (386   $ 469          $ (1   $ 39   
  

 

 

   

 

 

      

 

 

   

 

 

       

 

 

   

 

 

 

 

Derivatives designated as
hedging instruments for the nine
months ended March 31, 2013
and 2012:

   Loss
recognized in  OCI
(effective portion)
    Location
of (loss) gain reclassified
from OCI into income
(effective portion)
   (Loss) gain reclassified
from OCI into income
(effective  portion)
     Location of (loss) gain
recognized in income
(ineffective portion and
amount excluded from
effectiveness testing)
   (Loss) gain recognized
in income (ineffective
portion and
amount excluded from
effectiveness testing)
 
     2013     2012          2013     2012           2013     2012  

Foreign exchange forwards

   $ (503   $ (591   General and
administrative expenses
   $ (121   $ 163       General and
administrative expenses
   $ (1   $ 22   
  

 

 

   

 

 

      

 

 

   

 

 

       

 

 

   

 

 

 

Total

   $ (503   $ (591      $ (121   $ 163          $ (1   $ 22   
  

 

 

   

 

 

      

 

 

   

 

 

       

 

 

   

 

 

 

Included in the notional values above are $46.0 million and $59.1 million as of March 31, 2013 and June 30, 2012, respectively, of derivatives held as economic hedges primarily to hedge intercompany loans denominated in currencies other than the functional currency. The effects of derivatives that have not been designated as hedging instruments on the condensed consolidated statement of operations for the three and nine months ended March 31, 2013 and 2012 are as follows:

 

          (Loss) gain recognized in income  
          Three Months Ended      Nine Months Ended  

Derivatives not designated as hedging instruments:

  

Location of (Loss) gain recognized in income

   March 31,      March 31,  
      2013     2012      2013      2012  

Foreign exchange forwards

  

General and administrative expenses

   $ (146   $ 1,048       $ 1,928       $ 3,209   
     

 

 

   

 

 

    

 

 

    

 

 

 

Total

      $ (146   $ 1,048       $ 1,928       $ 3,209   
     

 

 

   

 

 

    

 

 

    

 

 

 

Note 7 — Retirement Benefits.

Defined Benefit Plans

Towers Watson sponsors both qualified and non-qualified defined benefit pension plans and other post-retirement benefit plans in North America and Europe. As of June 30, 2012, these funded and unfunded plans represented 98 percent of Towers Watson’s pension and other post-retirement benefit obligations and are disclosed herein. Towers Watson also sponsors funded and unfunded defined benefit pension plans in certain other countries as well, representing the remaining two percent of the liability.

 

11


Table of Contents

Components of Net Periodic Benefit Cost for Defined Benefit Pension Plans

The following tables set forth the components of net periodic benefit cost for the Company’s defined benefit pension plan for North America and Europe for the three and nine months ended March 31, 2013 and 2012:

 

                                                               
     Three Months Ended March 31,  
     2013     2012  
     North           North        
     America     Europe     America     Europe  

Service cost

   $    17,731      $ 3,074      $    14,225      $ 2,065   

Interest cost

        33,854           9,182           35,408          9,567   

Expected return on plan assets

     (46,586     (10,168     (42,158     (11,147

Amortization of net loss/(gain)

     11,440        1,441        11,462        (606

Amortization of prior service (credit)/cost

     (2,094     10        (2,084     10   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic benefit cost/(credit)

   $ 14,345      $ 3,539      $ 16,853      $ (111
  

 

 

   

 

 

   

 

 

   

 

 

 

 

                                                               
     Nine Months Ended March 31,  
     2013     2012  
     North           North        
     America     Europe     America     Europe  

Service cost

   $ 53,189      $ 9,221      $ 46,676      $ 6,196   

Interest cost

     101,566        27,545        106,224        28,700   

Expected return on plan assets

     (139,540     (30,505     (126,474     (33,440

Settlement

     —          —          —          4,325   

Amortization of net loss/(gain)

     34,325        4,324        21,913        (1,819

Amortization of prior service (credit)/cost

     (6,283     29        (6,253     31   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic benefit cost

   $ 43,257      $ 10,614      $ 42,086      $ 3,993   
  

 

 

   

 

 

   

 

 

   

 

 

 

Components of Net Periodic Benefit Cost for Other Postretirement Plans

The following table sets forth the components of net periodic benefit cost for the Company’s post-retirement plans for the three and nine months ended March 31, 2013 and 2012:

 

     Three Months Ended     Nine Months Ended  
     March 31,     March 31,  
     2013     2012     2013     2012  

Service cost

   $ 441      $ 747      $ 1,323      $ 2,242   

Interest cost

     2,197        2,743        6,590        8,228   

Expected return on plan assets

     (33     (33     (98     (99

Amortization of net loss

     83        553        250        1,658   

Amortization of prior service credit

     (2,051     (2,178     (6,152     (6,533
  

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic benefit cost

   $ 637      $ 1,832      $ 1,913      $ 5,496   
  

 

 

   

 

 

   

 

 

   

 

 

 

Employer Contributions to Defined Benefit Pension Plans

The Company made $63.5 million in contributions to the North American plans during the first nine months of fiscal year 2013 and anticipates making $5.5 million in contributions over the remainder of the fiscal year. The Company made $29.0 million in contributions to European plans during the first nine months of fiscal year 2013 and anticipates making $12.9 million in contributions over the remainder of the fiscal year.

Defined Contribution Plans

The cost of the Company’s contributions to the various U.S. defined contribution plans for the three months ended March 31, 2013 and 2012 amounted to $9.3 million and $7.9 million, respectively. The cost of the Company’s contributions to the plans for the nine months ended March 31, 2013 and 2012 amounted to $22.3 million and $20.8 million, respectively.

The cost of the Company’s contributions to the various U.K. defined contribution plans for the three months ended March 31, 2013 and 2012 amounted to $5.6 million and $5.8 million, respectively. The cost of the Company’s contributions to the plans for the nine months ended March 31, 2013 and 2012 amounted to $16.8 million and $16.4 million, respectively.

 

12


Table of Contents

Note 8 — Debt, Commitments and Contingent Liabilities

The debt, commitments and contingencies described below are currently in effect and would require Towers Watson, or domestic subsidiaries, to make payments to third parties under certain circumstances. In addition to commitments and contingencies specifically described below, Towers Watson has historically provided guarantees on an infrequent basis to third parties in the ordinary course of business.

Towers Watson Senior Credit Facility

On November 7, 2011, Towers Watson and certain subsidiaries entered into a five-year, $500 million revolving credit facility, which amount may be increased by an aggregate amount of $250 million, subject to the satisfaction of customary terms and conditions, with a syndicate of banks (the “Senior Credit Facility”), replacing a previous facility due to expire in December 2012. Borrowings under the Senior Credit Facility bear interest at a spread to either LIBOR or the Prime Rate. During the nine months ended March 31, 2013, the weighted-average interest rate on the Senior Credit Facility was 1.49%. We are charged a quarterly commitment fee, currently 0.175% of the Senior Credit Facility, which varies with our financial leverage and is paid on the unused portion of the Senior Credit Facility. Obligations under the Senior Credit Facility are guaranteed by Towers Watson and all of its domestic subsidiaries (other than Professional Consultants Insurance Company (“PCIC”), a majority-owned captive insurance company, and Stone Mountain Insurance Company (“SMIC”), a wholly-owned captive insurance company).

The Senior Credit Facility contains customary representations and warranties and affirmative and negative covenants. The Senior Credit Facility requires Towers Watson to maintain certain financial covenants that include a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Leverage Ratio (which terms in each case are defined in the Senior Credit Facility). In addition, the Senior Credit Facility contains restrictions on the ability of Towers Watson to, among other things, incur additional indebtedness; pay dividends; make distributions; create liens on assets; make acquisitions; dispose of property; engage in sale-leaseback transactions; engage in mergers or consolidations, liquidations and dissolutions; engage in certain transactions with affiliates; and make changes in lines of businesses. As of March 31, 2013, we were in compliance with our covenants.

As of March 31, 2013, Towers Watson had borrowings of $135.0 million outstanding under the Senior Credit Facility.

Letters of Credit under the Senior Credit Facility

As of March 31, 2013, Towers Watson had standby letters of credit totaling $24.9 million associated with our captive insurance companies in the event that we fail to meet our financial obligations. Additionally, Towers Watson had $1.7 million of standby letters of credit covering various other existing or potential business obligations. The aforementioned letters of credit are issued under the Senior Credit Facility, and therefore reduce the amount that can be borrowed under the Senior Credit Facility by the outstanding amount of these standby letters of credit.

Term Loan Agreement Due June 2017

On June 1, 2012, the Company entered into a five-year $250 million amortizing term loan facility (“the Term Loan”) with a consortium of banks. The interest rate on the term loan is based on the Company’s choice of one, three or six month LIBOR plus a spread of 1.25% to 1.75%, or alternatively the bank base rate plus 0.25% to 0.75%. The spread to each index is dependent on the Company’s consolidated leverage ratio. The weighted-average interest rate on the Term Loan during the nine months ended March 31, 2013 was 1.47%. The Term Loan amortizes at a rate of $6.25 million per quarter, beginning in September 2013, with a final maturity date of June 1, 2017. The Company has the right to prepay a portion or all of the outstanding Term Loan balance on any interest payment date without penalty.

This agreement contains substantially the same terms and conditions as our Senior Credit Facility, including guarantees from all of the domestic subsidiaries of Towers Watson (other PCIC and SMIC). The Company entered into the Term Loan as part of the financing of our acquisition of Extend Health (see Note 2).

Indemnification Agreements

Towers Watson has various agreements which provide that it may be obligated to indemnify the other party to the agreement with respect to certain matters. Generally, these indemnification provisions are included in contracts arising in the normal course of business and in connection with the purchase and sale of certain businesses. Although it is not possible to predict the maximum potential amount of future payments that may become due under these indemnification agreements because of the conditional nature of Towers Watson’s obligations and the unique facts of each particular agreement, Towers Watson does not believe any potential liability that might arise from such indemnity provisions is probable or material. There are no provisions for recourse to third parties, nor are any assets held by any third parties that any guarantor can liquidate to recover amounts paid under such indemnities.

 

13


Table of Contents

Legal Proceedings

From time to time, Towers Watson and its subsidiaries, including Watson Wyatt and Towers Perrin, are parties to various lawsuits, arbitrations or mediations that arise in the ordinary course of business. The matters reported on below are the material pending claims against Towers Watson and its subsidiaries. We do not expect the impact of claims not described below to be material to Towers Watson’s financial statements. We also receive subpoenas in the ordinary course of business and, from time-to-time, receive requests for information in connection with governmental investigations.

Towers Watson carries substantial professional liability insurance which, effective July 1, 2010, has been provided by SMIC. For the policy period beginning July 1, 2011 and ending July 1, 2012, certain changes were made to our professional liability insurance program. These changes remain in-force for the policy period beginning July 1, 2012 and ending July 1, 2013. Our professional liability insurance includes a self-insured retention of $1 million per claim. Towers Watson also retains $10 million in the aggregate above the $1 million self-insured retention per claim. SMIC provides us with $40 million of coverage per claim and in the aggregate, above the retentions. SMIC secured $25 million of reinsurance from unaffiliated reinsurance companies in excess of the $15 million SMIC retained layer. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies.

This structure effectively results in Towers Watson and SMIC bearing the first $25 million of loss per occurrence or in the aggregate above the $1 million per claim self-insured retention. As a wholly-owned captive insurance company, SMIC is consolidated into our financial statements. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies.

Before the Merger, Watson Wyatt and Towers Perrin each obtained substantial professional liability insurance from PCIC. A limit of $50 million per claim and in the aggregate was provided by PCIC subject to a $1 million per claim self-insured retention. PCIC secured reinsurance of $25 million attaching above the $25 million PCIC retained layer from unaffiliated reinsurance companies. Post-Merger, Towers Watson has a 72.86% ownership interest in PCIC and, as a result, PCIC’s results are consolidated in Towers Watson’s operating results. The PCIC insurance policies will continue to cover professional liability claims above a $1 million per claim self-insured retention for claims reported during the periods these policies were in effect, effectively resulting in self-insurance for the first $25 million of aggregate loss for each of Watson Wyatt and Towers Perrin above the $1 million per claim self-insured retention. As a result of consolidating PCIC’s results of operations in our consolidated financial statements, the impact of PCIC’s reserve development may result in fluctuations in Towers Watson’s earnings that could be significant.

We reserve for contingent liabilities based on ASC 450, Contingencies, when it is determined that a liability, inclusive of defense costs, is probable and reasonably estimable. The contingent liabilities recorded are primarily developed actuarially. Litigation is subject to many factors which are difficult to predict so there can be no assurance that in the event of a material unfavorable result in one or more claims, we will not incur material costs.

Former Towers Perrin shareholder litigation

A putative class action lawsuit filed by certain former shareholders of Towers Perrin (the “Dugan Action”) previously was reported in Amendment No. 3 to the Registration Statement on Form S-4/A (File No. 333-161705) filed on November 9, 2009 by the Jupiter Saturn Holding Company (the “Registration Statement”). As reported in the Registration Statement, the complaint was filed on November 5, 2009 against Towers Perrin, members of its board of directors, and certain members of senior management in the United States District Court for the Eastern District of Pennsylvania.

Plaintiffs in this action are former members of Towers Perrin’s senior management, who left Towers Perrin at various times between 1995 and 2000. The Dugan plaintiffs seek to represent a class of former Towers Perrin shareholders who separated from service on or after January 1, 1971, and who also meet certain other specified criteria. The complaint does not contain a quantification of the damages sought.

On December 9, 2009, Watson Wyatt was informed by Towers Perrin of a settlement demand from the plaintiffs in the Dugan Action. Although the complaint in the Dugan Action does not contain a quantification of the damages sought, plaintiffs’ settlement demand, which was orally communicated to Towers Perrin on December 8, 2009 and in writing on December 9, 2009, sought a payment of $800 million to settle the action on behalf of the proposed class. Plaintiffs requested that Towers Perrin communicate the settlement demand to Watson Wyatt.

On December 17, 2009, four other former Towers Perrin shareholders, all of whom voluntarily left Towers Perrin in May or June 2005 and all of whom are excluded from the proposed class in the Dugan Action, commenced a separate legal proceeding (the “Allen Action”) in the United States District Court for the Eastern District of Pennsylvania alleging the same claims in substantially the same form as those alleged in the Dugan Action. A fifth plaintiff joined this action on August 29, 2011. These plaintiffs are proceeding in their individual capacities and do not seek to represent a proposed class.

 

14


Table of Contents

On January 15, 2010, another former Towers Perrin shareholder who separated from service with Towers Perrin in March 2005 when Towers Perrin and EDS launched a joint venture that led to the creation of a corporate entity known as ExcellerateHRO (“eHRO”), commenced a separate legal proceeding (the “Pao Action”) in the United States District Court of the Eastern District of Pennsylvania alleging the same claims in substantially the same form as those alleged in the Dugan Action. Towers Perrin contributed its Towers Perrin Administrative Solutions (“TPAS”) business to eHRO and formerly was a minority shareholder (15%) of eHRO. Pao seeks to represent a class of former Towers Perrin shareholders who separated from service in connection with Towers Perrin’s contribution to eHRO of its TPAS business and who are excluded from the proposed class in the Dugan Action. Towers Watson is also named as a defendant in the Pao Action.

Pursuant to the Towers Perrin Bylaws in effect at the time of their separations, the Towers Perrin shares held by all plaintiffs were redeemed by Towers Perrin at book value when these individuals separated from employment. The complaints allege variously that there either was a promise that Towers Perrin would remain privately owned in perpetuity (Dugan Action) or that in the event of a change to public ownership plaintiffs would receive compensation (Allen and Pao Actions). Plaintiffs allege that by agreeing to sell their shares back to Towers Perrin at book value upon separation, they and other members of the putative classes relied upon these alleged promises, which they claim were breached as a result of the consummation of the Merger between Watson Wyatt and Towers Perrin. The complaints assert claims for breach of contract, breach of express trust, breach of fiduciary duty, promissory estoppel, quasi-contract/unjust enrichment, and constructive trust, and seek equitable relief including an accounting, disgorgement, rescission and/or restitution, and the imposition of a constructive trust. On January 20, 2010, the court consolidated the three actions for all purposes.

On February 22, 2010, defendants filed a motion to dismiss the complaints in their entireties. By order dated September 30, 2010, the court granted the motion to dismiss plaintiffs’ claim for a constructive trust and denied the motion with respect to all other claims alleged. Pursuant to the court’s September 30, 2010 order, defendants also filed answers to plaintiffs’ complaints on October 22, 2010. The parties have completed fact discovery. Neither the plaintiffs in Dugan nor the plaintiff in Pao have moved for class certification. Defendants filed a motion for summary judgment on all claims in all actions on December 23, 2011. The court heard argument on June 19, 2012, and on December 11, 2012 granted defendants’ motion, and entered judgment in favor of defendants on all claims. On January 10, 2013, plaintiffs filed a joint notice of their intent to appeal the court’s judgment to the U.S. Court of Appeals for the Third Circuit. On February 13, 2013, the parties were notified that the appeal had been assigned for mediation pursuant to the Third Circuit’s mediation program, and the mediation process is ongoing. The appellate court will not issue a briefing schedule for the appeal unless and until it has been informed the mediation was unsuccessful.

Towers Watson continues to believe the claims in these lawsuits are without merit and that the court’s decision to grant summary judgment in favor of defendants should be upheld on appeal. However, the outcome of any appeal is uncertain and may be unfavorable to Towers Watson. Given the stage of the proceedings, the Company has concluded that a loss is neither probable nor estimable, and that the Company is unable to estimate a reasonably possible loss or range of loss.

Acument Global Technologies, Inc.

In a letter to the Company dated January 26, 2011, Acument Global Technologies, Inc. (“Acument”) and the Acument Global Technologies, Inc. Pension Plan (the “Plan”) claimed that Towers Watson breached its fiduciary duties under the Employee Retirement Income Security Act of 1974 (“ERISA”) in connection with advice provided to Acument relating to investment of certain assets of the Plan in the Westridge Capital Management Enhancements Funds (the “Westridge Funds”). Acument and the Plan demanded that the Company make the Plan whole for losses and damages allegedly sustained as a result of Acument’s decision to invest in the Westridge Funds. Watson Wyatt Investment Consulting, Inc. (“WWIC”), now known as Towers Watson Investment Services, Inc. (“TWIS”), provided investment consulting services to Acument between December 1, 2007 and April 30, 2010. In connection with those services, WWIC recommended an investment in the Westridge Funds. In July 2008, Acument made a $47.0 million investment in the Westridge Funds. During the period December 1, 2008 through January 22, 2009, Acument made additional investments of $9.5 million, bringing the aggregate investment of the Plan’s assets in the Westridge Funds to $56.5 million.

As the result of information obtained during an investigation of Westridge Capital Management, its affiliates WG Trading Investors, L.P. and WG Trading Company, L.P. (collectively referred to as “Westridge”) and their principals, commenced by the National Futures Association on February 5, 2009, the Commodities Future Trading Commission filed suit against Westridge and its principals alleging violations of the Commodity Exchange Act. This resulted in a court-supervised receivership of the assets of Westridge. The Securities and Exchange Commission (“SEC”) filed a separate suit on February 25, 2009 against Westridge and its principals alleging violations of the federal securities laws. In its complaint, the SEC alleges that Westridge had become a fraudulent investment scheme by which its principals purportedly misappropriated approximately $553 million from a number of highly sophisticated institutional investors, including public pension and retirement plans and educational institutions, some of which were investing in Westridge as late as February 6, 2009. To date, Acument has recovered approximately $38.2 million of its investment in the Westridge Funds from the receivership. The Company declined Acument’s demand for compensation.

On January 20, 2012, Acument and the Acument Pension Plan (referred to together as “Acument”) filed suit against the Company and TWIS in the United States District Court for the Southern District of New York. The complaint alleges four counts of breach of

 

15


Table of Contents

fiduciary duty under ERISA, claiming principally alleged deficiencies in the Company’s due diligence relating to Westridge and in the disclosures made to Acument concerning Westridge and the nature of the investment. Acument seeks to recover an unspecified amount comprised primarily of loss of principal, investment losses, fees paid for consulting services, and attorney’s fees. The Company has filed an answer to the complaint denying all claims and asserting affirmative defenses and plans to continue to defend vigorously against these legal proceedings. The discovery phase of these legal proceedings has commenced. A mediation took place on September 5, 2012. The dispute remains extant. At this time, no material loss is probable in excess of amounts currently accrued.

Note 9 — Nonconsolidated Variable Interest Entities.

On February 1, 2013 Towers Watson completed the acquisition of Oxford Investment Partners (“OXIP”), a fund management company, dedicated to meeting the specific investment objectives of its clients. Although the consideration and the fair value of the assets acquired including goodwill is immaterial to our financial position and results of operations the acquisition resulted in significant accounting judgments. Some of the funds managed by OXIP are variable interest entities (“VIEs”).

VIEs are entities that lack one or more of the characteristics of a voting interest entity and therefore require a different approach in determining which party involved with the VIE should consolidate the entity. With a VIE, either the entity does not have sufficient equity at risk to finance its activities without additional subordinated financial support from other parties or the entity has equity investors that do not have the ability to make significant decisions relating to the entity’s operations through voting rights. The entity that has a controlling financial interest in a VIE is referred to as the primary beneficiary and is required to consolidate the VIE.

Through the acquisition of OXIP, we manage approximately $1 billion of assets in funds that are considered VIE’s and for which our management fee is considered a variable interest. We evaluated these funds and determined that we are not the primary beneficiary. Therefore, the funds are not consolidated. Our maximum exposure to loss of these unconsolidated VIEs is limited to collection of any unpaid management fees.

Note 10 — Comprehensive Income.

Comprehensive income /(loss) as presented in the accompanying condensed consolidated statements of comprehensive income includes net income, foreign currency translation, defined pension and post-retirement benefit costs, hedge effectiveness and unrealized gain/loss on available-for-sale securities. Additional information for the other comprehensive income/(loss) recognized during the three and nine months ended March 31, 2013 and March 31, 2012 by component are provided in the following tables:

 

                                                                                         
     Three months ended
March 31, 2013
    Three months ended
March 31, 2012
 
     Before tax     Tax     After tax     Before tax     Tax     After tax  

Other comprehensive (loss)/income:

            

Foreign currency translation

   $ (96,135   $ —        $ (96,135   $  38,260      $ —        $ 38,260   

Defined pension and post-retirement benefit costs

     (6,303       2,166        (4,137     3,648        (328     3,320   

Hedge effectiveness

     942        (396     546        23        (9     14   

Available-for-sale securities

     132        (39     93        (152           47        (105
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss)/income before non-controlling interests

   $ (101,364   $ 1,731      $ (99,633   $ 41,779      $ (290   $  41,489   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

                                                                                         
     Nine months ended
March 31, 2013
    Nine months ended
March 31, 2012
 
     Before tax     Tax     After tax     Before tax     Tax     After tax  

Other comprehensive (loss)/income:

            

Foreign currency translation

   $ (47,412   $ —        $ (47,412   $ (48,486   $ —        $ (48,486

Defined pension and post-retirement benefit costs

     (31,258     9,998        (21,260     11,953        (1,208     10,745   

Hedge effectiveness

     (382     132        (250     (754     302        (452

Available-for-sale securities

     216        (67     149        (1,006     294        (712
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss)/income before non-controlling interests

   $   (78,836   $ 10,063      $ (68,773   $ (38,293   $ (612   $ (38,905
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

16


Table of Contents

Note 11 — Restricted Stock.

In conjunction with the Merger, shares of Towers Watson common stock issued to Towers Perrin shareholders were divided among four series of non-transferable Towers Watson common stock, Classes B-1, B-2, B-3 and B-4, each with a par value of $0.01 per share. The shares discussed below reflect a reduction of shares through our tender offer and our secondary public offering and by the acceleration of vesting due to involuntary associate terminations detailed below. In addition, on January 31, 2011, we completed the acquisition of EMB and issued 113,858 shares of Class B-3 and 113,858 shares of Class B-4 common stock, par value $0.01 per share, to the sellers as consideration. The Class B-4 common stock generally converts into freely tradable Class A common stock on the same schedule as the Class B-4 shares granted to the Towers Perrin shareholders discussed below.

On January 1, 2011, 5,642,302 shares of Class B-1 common stock converted to freely tradable Class A common stock. On January 1, 2012, 5,547,733 shares of Class B-2 common stock converted to freely tradable Class A common stock. On January 1, 2013, 5,661,591 shares of Class B-3 common stock converted to freely tradable Class A common stock. The remaining 5,374,070 outstanding shares of Towers Watson Class B-4 common stock will convert on a one-for-one basis into shares of freely transferable shares of Towers Watson Class A common stock on January 1, 2014.

The Towers Perrin restricted stock unit (“RSU”) holders received 10% of the total consideration issued to Towers Perrin shareholders in conjunction with the Merger. The RSUs were converted into 4,248,984 shares of Towers Watson Restricted Class A Common Stock (“Restricted Class A shares”), of which an estimated 10% were expected to be forfeited by associate Restricted Class A shareholders who were subject to a service condition. The service condition was fulfilled from the grant date through each of the three annual periods from January 1, 2010 until December 31, 2012. The restriction lapsed annually on January 1 and the Restricted Class A shares became freely tradable shares of Class A common stock on such dates.

In January 2013, 482,463 forfeited shares were canceled and a corresponding amount (plus associated dividends) was distributed from treasury stock to Towers Perrin shareholders in the form of Class A shares as of December 31, 2009 in proportion to their ownership in Towers Perrin on the date of the Merger. Shareholders of Restricted Class A shares had voting rights and received dividends upon annual vesting of the shares. The final 1,109,212 outstanding Restricted Class A shares became freely tradable on January 1, 2013 and were further reduced by shares withheld for tax purposes.

For the three months ended March 31, 2013, we reversed $5.3 million of previously recorded compensation expense based on the actual number of shares forfeited upon the final vesting date of January 1, 2013. Our estimated forfeiture rate was 10% and our actual forfeitures were 11%. For the nine months ended March 31, 2013, we recorded $3.6 million of non-cash share-based compensation expense in connection with the issuance of Towers Watson Restricted Class A common stock to Towers Perrin RSU holders in the Merger.

For the three and nine months ended March 31, 2012, we recorded $4.7 million and $25.6 million, respectively, of non-cash share-based compensation expense in connection with the issuance of Towers Watson Restricted Class A common stock to Towers Perrin RSU holders in the Merger.

The graded method of expense methodology assumes that the restricted shares were issued to Towers Perrin RSU holders in equal amounts of shares which vested as separate awards over one, two and three years.

Note 12 — Share-Based Compensation.

Restricted Stock Units

Executives and Employees

The Compensation Committee of our Board of Directors approves performance-vested restricted stock unit awards pursuant to the Towers Watson & Co. 2009 Long Term Incentive Plan. RSUs are designed to provide us an opportunity to offer our long-term incentive program (LTIP) and to provide key executives with a long-term stake in our success. RSUs are notional, non-voting units of measurement based on our common stock. Under the RSU agreement, participants become vested in a number of RSUs based on the achievement of specified levels of financial performance during the performance period set forth in the agreement, provided that the participant remains in continuous service with us through the end of the performance period. Any RSUs that become vested are payable in shares of our Class A Common Stock. Dividend equivalents will accrue on RSUs and vest to the same extent as the underlying shares. The form of performance-vested restricted stock unit award agreement includes a provision whereby the Committee could provide for continuation of vesting of restricted stock units upon an employee’s termination under certain circumstances such as a qualified retirement. This definition of qualified retirement is age 55 and with 15 years of experience at the company and a minimum of one year of service in the performance period.

2013 LTIP. During the first quarter of fiscal year 2013, the Compensation Committee of the Board of Directors approved a grant of 121,075 RSUs to certain of our executive officers. Awards were based on the value of the executive officer’s annual base salary and a

 

17


Table of Contents

multiplier, which is then converted into a target number of RSUs based on our closing stock price as of the date of grant. Between 0% and 204% of the target number of RSUs will vest based on the extent to which specified performance metrics are achieved over the three-year performance period from July 1, 2012 to June 30, 2015, subject to the executive officers’ continued employment with us through the end of the performance period, except in the case of a qualified retirement. The Compensation Committee approved the grants and established adjusted three-year average EPS and revenue growth during the performance period as the performance metrics for the awards. For participants that met the requirement for qualified retirement, we record the expense of their awards over the one year service period as performed. We will adjust the stock-based compensation for their awards during the performance period based upon the level of performance achieved. For the three and nine months ended March 31, 2013, we recorded $1.4 million and $4.3 million, respectively, of stock-based compensation related to these grants.

2012 LTIP. During the fiscal year ended June 30, 2012, 86,188 RSUs were granted to certain of our executive officers. Awards are based on the value of the executive officer’s annual base salary and a multiplier, which is then converted into a target number of RSUs based on our closing stock price as of the date of grant which was between $63.73 and $63.94. Between 0% and 204% of the target number of RSUs will vest based on the extent to which specified performance metrics are achieved over the three-year performance period from July 1, 2011 to June 30, 2014, subject to the executive officers’ continued employment with us through the end of the performance period, except in the case of a qualified retirement. The Compensation Committee approved the grants and established adjusted EBITDA margin and revenue growth during the performance period as the performance metrics for the awards. For participants that met the requirement for qualified retirement, we record the expense of their awards over the one year service period as performed. We will adjust the stock-based compensation for their awards during the performance period based upon the level of performance achieved. For the three and nine months ended March 31, 2013, we recorded $0.3 million and $1.8 million, respectively, of stock-based compensation related to these grants. For the three and nine months ended March 31, 2012, we recorded $1.9 million and $5.3 million, respectively, of stock-based compensation related to these grants.

2011 LTIP. During the three months ended September 30, 2010, 125,192 RSUs were granted to certain of our executive officers. Awards are based on the value of the executive officer’s annual base salary and a multiplier, which is then converted into a target number of RSUs based on our closing stock price as of the date of grant of $45.25. Between 0% and 204% of the target number of RSUs will vest based on the extent to which specified performance metrics are achieved over the three year performance period from July 1, 2010 to June 30, 2013, subject to the executive officers’ continued employment with us through the end of the performance period. The Compensation Committee approved the grants and established adjusted EBITDA margin for the six-month period ending June 30, 2013 and revenue growth during the performance period (based on fiscal year 2013 revenue versus fiscal year 2010 revenue) as the performance metrics for the awards. We will adjust the stock-based compensation for their awards during the performance period based upon the level of performance achieved. For the three and nine months ended March 31, 2013, we recorded $0.2 million and $0.7 million, respectively, of stock-based compensation related to these grants. For the three and nine months ended March 31, 2012, we recorded $0.2 million and $5.3 million, respectively, of stock-based compensation related to these grants.

2012 SEP. During the quarter ended September 30, 2012, 147,503 RSUs were granted to certain employees under our Select Equity Plan. The RSUs will vest annually over a three-year period. We assumed a 5% forfeiture rate with these awards. For the three and nine months ended March 31, 2013, we recorded $1.2 million, and $3.5 million, respectively, of non-cash stock based compensation related to these grants.

2011 SEP. During the quarter ended September 30, 2011, 577,191 RSUs were granted to certain employees under our Select Equity Plan, of which 288,595 were vested immediately in conjunction with our annual fiscal year 2011 performance bonus. The remaining 288,595 RSUs vest annually over a three-year period. We assumed a 5% forfeiture rate with these awards. For the three and nine months ended March 31, 2013, we recorded $1.1 million, and $3.3 million, respectively, of non-cash stock based compensation related to these grants. For the three and nine months ended March 31, 2012, we recorded $2.3 million and $8.3 million, respectively, of non-cash stock based compensation related to these grants.

Outside Directors

The Towers Watson & Co. Compensation Plan for Non-Employee Directors provides for cash and stock compensation for outside directors. During the three months ended September 30, 2012, 16,027 restricted stock units were granted for the annual award for outside directors for service on the board of directors in equal quarterly installments over fiscal year 2013. During the three months ended September 30, 2011, 12,783 restricted stock units were granted for the annual award for outside directors for service on the board of directors in equal quarterly installments over fiscal year 2012. In fiscal year 2010, 22,149 restricted stock units were granted for the initial award for outside directors for service on the board of directors, which vest in equal annual installments over a three-year period ending January 1, 2013. We recorded non-cash stock based compensation related to these awards for outside directors of $0.1 million and $0.9 million, respectively, for the three and nine months ended March 31, 2013, and $0.1 million and $0.9 million, respectively, for the three and nine months ended March 31, 2012.

Stock Options

There were no grants of stock options during the three and nine months ended March 31, 2013.

 

18


Table of Contents

In May 2012, we assumed the Extend Health, Inc. 2007 Equity Incentive Plan and converted the outstanding unvested employee stock options into 377,614 Towers Watson’s stock option awards using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of the vested stock options was calculated using the Black-Scholes model with a volatility and risk-free interest rate over the expected term of each group of options using the fair value share price of Towers Watson’s closing share price on the date of acquisition. The fair value of the new awards was less than the acquisition date fair value of the replaced Extend Health options; accordingly, no compensation expense was recorded. The fair value of 199,620 of the 377,614 outstanding options using Towers Watson graded vesting methodology from the date of grant to the acquisition date, representing the employee service provided to date, was $11.2 million and was added to the transaction consideration. The fair value of the remaining 177,994 unvested options, less 10% estimated forfeitures, was $7.9 million, and will be recorded over the future vesting periods. We accelerated and paid participants the net cash value and exercise price for 43,317 of unvested options that would have vested between the acquisition date and June 30, 2012 and recorded $0.9 million of related compensation expense in fiscal 2012. We recorded non-cash stock based compensation related to these awards of $1.1 million and $5.0 million, respectively, for the three and nine months ended March 31, 2013.

Note 13 — Income Taxes.

Provision for income taxes for the three and nine months ended March 31, 2013 was $41.9 million and $110.8 million, respectively, compared to $41.2 million and $113.6 million, respectively, for the three and nine months ended March 31, 2012. The effective tax rate was 32.2% for the nine months ended March 31, 2013 and 36.8% for the nine months ended March 31, 2012. The change in the effective tax rate is primarily due to current year income tax benefits resulting from legal entity restructurings of 1.4% and income tax benefits on the release of uncertain tax positions of 1.2% resulting from the settlement of an IRS examination during the quarter. The change in effective rate is also due to prior year increases resulting from the establishment of valuation allowances in foreign jurisdictions of 0.6% and increases in uncertain tax positions of 1.0% in the nine months ended March 31, 2012.

During the quarter, the Company settled IRS examinations for fiscal year 2010 and fiscal year 2011, which resulted in a release of approximately $4.0 million of uncertain tax positions. It is reasonably possible that during the next 12 months, the Company’s liability for uncertain tax positions may change by a significant amount. The Company may settle additional tax examinations or have lapses in statute of limitations for different amounts than the Company has accrued. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more likely than not standard if such positions are not upheld. Conversely, the Company could settle positions with the tax authorities for amounts lower than have been accrued or extinguish a position through payment. The Company believes the outcomes which are reasonably possible within the next 12 months may result in a reduction in the liability for uncertain tax positions in the range of approximately $21.0 million to $22.0 million, excluding interest and penalties.

We have not provided U.S. federal income taxes on undistributed foreign earnings of our foreign subsidiaries because such earnings are considered indefinitely reinvested outside the United States. We believe the Company’s cash projections, current cash position, and access to capital markets will allow it to meet its U.S. cash obligations without repatriating foreign earnings. Further, non-U.S. cash is used for working capital needs of our non-U.S. operations and may be used for foreign restructuring expenses or acquisitions. However, as of March 31, 2013, the Company changed its assertion with respect to its U.K. subsidiary and plans on making a distribution of approximately $165.0 million by June 30, 2013. The change in assertion is primarily due to changes in foreign cash and liquidity requirements and our decision to pay down certain U.S. debt. ASC 740, Income Taxes, requires a Company to recognize income tax expense when it becomes apparent that some or all of the undistributed earnings of the foreign subsidiary will be remitted in the foreseeable future. The Company has not recorded an income tax expense for the distribution as the estimated additional U.S. tax cost is expected to be insignificant due to available foreign tax credits from the dividend equivalent to the U.S. statutory tax rate.

On January 2, 2013, the American Taxpayer Relief Act of 2012 (the “Act”) was enacted and extended several expired or expiring temporary business tax provisions, including the active financing income exception, the controlled foreign corporation look through, and the research and development credit. Pursuant to ASC 740, the effects of new legislation are recognized in the period of enactment. The Company has determined there are no material impacts to tax expense as a result of the Act, and has recorded the income tax effects in the third quarter.

Note 14 — Segment Information.

Towers Watson has four reportable operating segments or business areas:

 

   

Benefits

 

   

Risk and Financial Services

 

   

Talent and Rewards

 

   

Exchange Solutions

 

19


Table of Contents

Towers Watson’s chief operating decision maker is its chief executive officer. It was determined that Towers Watson operational data used by the chief operating decision maker is that of the segments. Management bases strategic goals and decisions on these segments and the data presented below is used to assess the adequacy of strategic decisions, the method of achieving these strategies and related financial results.

In connection with the acquisition of Extend Health in May 2012, we added a fourth segment called Exchange Solutions. We designated the Extend Health business as a stand-alone fourth segment due to the differences between Extend Health’s business strategy, market and operating margins and that of the other three segments.

Management evaluates the performance of its segments and allocates resources to them based on net operating income on a pre-bonus, pre-tax basis. Revenue includes amounts that were directly incurred on behalf of our clients and reimbursed by them (reimbursable expenses).

The table below presents specified information about reported segments for the three months ended March 31, 2013:

 

     Benefits      Risk and
Financial Services
     Talent and
Rewards
     Exchange
Solutions
     Total  

Revenue (net of reimbursable expenses)

   $ 523,489       $ 225,382       $ 124,914       $ 30,621       $ 904,406   

Net operating income

     184,304         65,314         13,179         14,648         277,445   

The table below presents specified information about reported segments for the three months ended March 31, 2012:

 

     Benefits      Risk and
Financial Services
     Talent and
Rewards
     Exchange
Solutions
     Total  

Revenue (net of reimbursable expenses)

   $ 520,144       $ 219,722       $ 131,128       $ —         $ 870,994   

Net operating income

     193,419         65,039         17,062         —           275,520   

The table below presents specified information about reported segments for the nine months ended March 31, 2013:

 

     Benefits      Risk and
Financial Services
     Talent and
Rewards
     Exchange
Solutions
    Total  

Revenue (net of reimbursable expenses)

   $ 1,500,035       $ 625,418       $ 441,334       $ 60,259      $ 2,627,046   

Net operating income

     505,975         147,442         99,048         (1,245     751,220   

The table below presents specified information about reported segments for the nine months ended March 31, 2012:

 

     Benefits      Risk and
Financial Services
     Talent and
Rewards
     Exchange
Solutions
     Total  

Revenue (net of reimbursable expenses)

   $ 1,450,170       $ 618,871       $ 440,111       $ —         $ 2,509,152   

Net operating income

     499,963         168,507         98,036         —           766,506   

 

20


Table of Contents

The table below presents a reconciliation of the information reported by segment to the consolidated amounts for the three and nine months ended March 31, 2013 and 2012:

 

     Three Months Ended     Nine Months Ended  
     March 31,     March 31,  
     2013     2012     2013     2012  

Revenue:

        

Total segment revenue

   $ 904,406      $ 870,994      $ 2,627,046      $ 2,509,152   

Reimbursable expenses and other

     36,561        30,522        94,415        82,425   
  

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

   $ 940,967      $ 901,516      $ 2,721,461      $ 2,591,577   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Operating Income:

        

Total segment net operating income

   $ 277,445      $ 275,520      $ 751,220      $ 766,506   

Differences in allocation methods (1)

     (720     (7,285     11,696        1,960   

Amortization of intangibles

     (19,395     (17,728     (59,237     (48,393

Transaction and integration expenses

     (12,328     (21,411     (30,753     (65,221

Stock-based compensation (2)

     1,305        (7,572     (17,459     (39,415

Discretionary compensation

     (99,659     (90,545     (278,405     (275,263

Payroll tax on discretionary compensation

     (5,880     (5,312     (15,975     (16,158

Change in accounting method for pension (3)

     —          (6,237     —          (6,237

Other, net

     (1,190     (10,547     (14,121     (14,753
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

   $ 139,578      $ 108,883      $ 346,966      $ 303,026   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) Depreciation, general and administrative, pension, and medical costs are allocated to our segments based on budgeted expenses determined at the beginning of the fiscal year, as management believes that these costs are largely uncontrollable to the segment. To the extent that the actual expense base upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally allocated expenses and the actual expense that we report for GAAP purposes.
(2) Stock-based compensation excludes RSUs granted in conjunction with our performance bonus, which are included in discretionary compensation.
(3) The Company had a net impact of $6.2 million during the prior year as a result of the cumulative effect of the change in accounting method of $9.5 million offset by a reduction in net periodic cost of $3.3 million.

 

21


Table of Contents

Note 15 — Earnings Per Share.

We present earnings per share (“EPS”) using the two-class method. This method addresses whether awards granted in share-based transactions are participating securities prior to vesting and therefore need to be included in the earning allocation in computing earnings per share using the two-class method. This method requires non-vested share-based payment awards that have non-forfeitable rights to dividends or dividend equivalents to be treated as a separate class of securities in calculating earnings per share. Our participating securities include non-vested restricted stock. On January 1, 2013, all remaining outstanding shares of this restricted stock vested and were converted to freely tradable shares of Towers Watson Class A common stock. See Note 11 for further information. The components of basic and diluted earnings per share are as follows:

 

     Three Months Ended March 31,  
     2013      2012  
     Income     Shares      Per Share
Amount
     Income     Shares      Per Share
Amount
 

Basic EPS

               

Net income attributable to controlling interests

   $ 94,916            $   68,234        

Less: Income allocated to participating securities

     —                (1,608     
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Income available to common shareholders

   $   94,916        70,530       $ 1.35       $ 66,626        69,935       $ 0.95   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Diluted EPS

               

Share-based compensation awards

     —          546            —          330      
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Income available to common shareholders

   $ 94,916        71,076       $ 1.34       $ 66,626        70,265       $ 0.95   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

     Nine Months Ended March 31,  
     2013      2012  
     Income     Shares      Per Share
Amount
     Income     Shares      Per Share
Amount
 

Basic EPS

               

Net income attributable to controlling interests

   $ 235,933            $ 194,877        

Less: Income allocated to participating securities

     (3,289           (6,660     
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Income available to common shareholders

   $ 232,644        69,977       $ 3.32       $ 188,217        69,903       $ 2.69   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Diluted EPS

               

Share-based compensation awards

     —          545            —          282      
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Income available to common shareholders

   $ 232,644        70,522       $ 3.29       $ 188,217        70,185       $ 2.68   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Note 16 — Recent Accounting Pronouncements.

Adopted

On July 27, 2012, the FASB issued ASU 2012-02, “Intangibles — Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment” which amended the guidance in ASC 350-30 on testing indefinite-lived intangible assets, other than goodwill, for impairment. The FASB issued the ASU in response to feedback on ASU 2011-08 which amended the goodwill impairment testing requirements by allowing an entity to perform a qualitative impairment assessment before proceeding to the two-step impairment test. Similarly, under ASU 2012-02, an entity testing an indefinite-lived intangible asset for impairment has the option of performing a qualitative assessment before calculating the fair value of the asset. If the entity determines, on the basis of qualitative factors, that the fair value of the indefinite-lived intangible asset is not more likely than not (i.e., a likelihood of more than 50 percent) impaired, the entity would not need to calculate the fair value of the asset. The ASU did not revise the requirement to test indefinite-lived intangible assets annually for impairment. In addition, the ASU does not amend the requirement to test these assets for impairment between annual tests if there is a change in events or circumstances; however, it does revise the examples of events and circumstances that an entity should consider in interim periods. ASU 2012-02 is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted and the Company will adopt this ASU as part of its fiscal 2013 annual impairment test performed as of April 1, 2013 during the upcoming fourth quarter. At this time, there is no impact expected to our financial statements as a result of adopting this provision.

Not Yet Adopted

On February 5, 2013, the FASB issued ASU 2013-02, “Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,” which requires entities to disclose additional information about items reclassified out of accumulated other comprehensive income (“AOCI”). The requirements include by component disclosures of changes in AOCI

 

22


Table of Contents

balances along with the related income tax benefit or expense and significant items reclassified out of AOCI. ASU 2013-2 is effective for annual periods, and interim periods within those years, beginning after December 15, 2012, and the amendments are to be applied prospectively. While early adoption is permitted, the Company plans to adopt the new requirements in its reporting for the first quarter of the Company’s fiscal year 2014. The Company expects no material impact to our financial statements as a result of adopting this provision.

 

23


Table of Contents

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Executive Overview

General

Towers Watson, formed on January 1, 2010 upon the merger (the “Merger”) of Watson Wyatt Worldwide, Inc. and Towers, Perrin, Forster & Crosby, Inc., is a global professional services firm focusing on providing human capital and financial consulting services.

At Towers Watson, we bring together professionals from around the world — experts in their areas of specialty — to deliver the perspectives that give organizations a clear path forward. We do this by working with clients to develop solutions in the areas of benefits, risk and capital management, and talent and rewards.

We help our clients enhance business performance by improving their ability to attract, retain and motivate qualified employees. We focus on delivering consulting services that help organizations anticipate, identify and capitalize on emerging opportunities in human capital management. We also provide independent financial advice regarding all aspects of life insurance and general insurance, as well as investment advice to help our clients develop disciplined and efficient strategies to meet their investment goals. We operate the largest private Medicare exchange in the United States. Through this exchange, we help our clients to move to a more sustainable economic model by capping and controlling the costs associated with retiree healthcare benefits.

As leading economies worldwide become more service-oriented, human resources and financial management have become increasingly important to companies and other organizations. The heightened competition for skilled employees, unprecedented changes in workforce demographics, regulatory changes related to compensation and retiree benefits, and rising employee-related costs have increased the importance of effective human capital management. Insurance and investment decisions have become increasingly complex and important in the face of changing economies and dynamic financial markets. Towers Watson helps its clients address these issues by combining expertise in human capital and financial management with consulting and technology solutions, to improve the design and implementation of various human resources and financial programs, including compensation, retirement, health care, and insurance and investment plans.

The human resources consulting industry, although highly fragmented, is highly competitive. It is composed of major human capital consulting firms, specialty firms, consulting arms of accounting firms and information technology consulting firms.

In the short term, our revenue is driven by many factors, including the general state of the global economy and the resulting level of discretionary spending, the continuing regulatory compliance requirements of our clients, changes in investment markets, the ability of our consultants to attract new clients or provide additional services to existing clients, the impact of new regulations in the legal and accounting fields and the impact of our ongoing cost saving initiatives. In the long term, we expect that our financial results will depend in large part upon how well we succeed in deepening our existing client relationships through thought leadership and a focus on developing cross-business solutions, actively pursuing new clients in our target markets, cross selling and making strategic acquisitions. We believe that the highly fragmented industry in which we operate offers us growth opportunities, because we provide a unique business combination of benefits and human capital consulting, as well as risk and capital management and strategic technology solutions.

Overview of Towers Watson

Towers Watson is a global professional services firm focusing on providing human capital and financial consulting services. Towers Watson provides services in four principal areas: Benefits, Risk and Financial Services, Talent and Rewards, and Exchange Solutions, operating from 113 cities in 37 countries throughout North America, Europe, Asia-Pacific and Latin America. Towers Watson employed approximately 14,300 and 14,200 full-time associates as of March 31, 2013 and June 30, 2012, respectively, in the following segments:

 

     March 31,      June 30,  
     2013      2012  

Benefits

     6,700         6,600   

Risk and Financial Services

     2,600         2,500   

Talent and Rewards

     2,300         2,400   

Exchange Solutions

     300         300   

Other

     300         300   

Business Services (incl. Corporate and field support)

     2,100         2,100   
  

 

 

    

 

 

 

Total associates

     14,300         14,200   
  

 

 

    

 

 

 

 

24


Table of Contents

Segments

We provide services in four business segments: Benefits, Risk and Financial Services, Talent and Rewards, and Exchange Solutions.

Benefits Segment. The Benefits segment is our largest and most established segment. This segment has grown through business combinations as well as strong organic growth. It helps clients create and manage cost-effective benefits programs that help them attract, retain and motivate a talented workforce.

The Benefits segment provides benefits consulting and administration services through four primary lines of business:

 

   

Retirement;

 

   

Health and Group Benefits;

 

   

Technology and Administration Solutions; and

 

   

International Consulting.

Retirement supports organizations worldwide in designing, managing, administering and communicating all types of retirement plans. Health and Group Benefits provides advice on the strategy, design, financing, delivery, ongoing plan management and communication of health and group benefit programs. Through our Technology and Administration Solutions line of business, we deliver cost-effective benefit outsourcing solutions. The International Consulting Group provides expertise in dealing with international human capital management and related benefits and compensation advice for corporate headquarters and their subsidiaries. A significant portion of the revenue in this segment is from recurring work, driven in large part by the heavily regulated nature of employee benefits plans and our clients’ annual needs for these services. For the nine months ended March 31, 2013, the Benefits segment contributed 57% of our segment revenue. For the same period, approximately 43% of the Benefits segment’s revenue originated from outside the United States and is thus subject to translation exposure resulting from foreign exchange rate fluctuations.

Risk and Financial Services Segment. Within the Risk and Financial Services segment, our second largest segment, we have three primary lines of business:

 

   

Risk Consulting and Software (“RCS”);

 

   

Investment Consulting and Solutions (“Investment”); and

 

   

Reinsurance and Insurance Brokerage (“Brokerage”).

The Risk and Financial Services segment accounted for 24% of our segment revenue for the nine months ended March 31, 2013. Approximately 68% of the segment’s revenue for the nine months ended March 31, 2013 originated from outside the United States and is thus subject to translation exposure resulting from foreign exchange rate fluctuations. The segment has a strong base of recurring revenue, driven by long-term client relationships in reinsurance brokerage services, retainer investment consulting relationships, consulting services on financial reporting, and actuarial opinions on property/casualty loss reserves. Some of these relationships have been in place for more than 20 years. A portion of the revenue is related to project work, which is more heavily dependent on the overall level of discretionary spending by clients. This work is favorably influenced by strong client relationships, particularly related to mergers and acquisitions consulting. Major revenue growth drivers include changes in regulations, the level of mergers and acquisitions activity in the insurance industry, growth in pension and other asset pools, and reinsurance retention and pricing trends.

Talent and Rewards Segment. Our third largest segment, Talent and Rewards, is focused on three primary lines of business:

 

   

Executive Compensation;

 

   

Rewards, Talent and Communication; and

 

   

Data, Surveys and Technology.

The Talent and Rewards segment accounted for approximately 17% of our segment revenue for the nine months ended March 31, 2013. Few of the segment’s projects have a recurring element. As a result, this segment is most sensitive to changes in discretionary spending due to cyclical economic fluctuations. Approximately 48% of the segment’s revenue for the nine months ended March 31, 2013 originated from outside the United States and is thus subject to translation exposure resulting from foreign exchange rate fluctuations. Revenue for Talent and Rewards consulting has minimal seasonality, with a small degree of heightened activity in the

 

25


Table of Contents

last quarter of the fiscal year during the annual compensation, benefits and survey cycles. Major revenue growth drivers in this group include demand for workforce productivity improvements and labor cost reductions, focus on high performance culture, globalization of the workforce, changes in regulations and benefits programs, mergers and acquisitions activity, and the demand for universal metrics related to workforce engagement.

Exchange Solutions Segment. Our fourth largest segment, Exchange Solutions, has one line of business:

 

   

Extend Health.

We established our fourth segment, Exchange Solutions, when we acquired Extend Health in May 2012, and our first quarter of fiscal year 2013 was our first full quarter of operations. The Exchange Solutions segment accounted for 2% of our segment revenue for the nine months ended March 31, 2013. Exchange Solutions operates the largest private Medicare insurance exchange in the United States. Our core solution enables employers to transition their retirees to individual, defined contribution health plans at an annual cost that the employer controls — versus group-based, defined benefit health plans, which have uncertain annual costs. By moving to a defined contribution approach, our clients can provide their retirees with the same or better health care benefits at a lower overall cost. Most Exchange Solutions’ revenues come from the commissions we receive from insurance carriers for enrolling individuals into their health plans. This revenue increases as the number of enrolled members grows. Exchange Solutions experiences seasonality due to the majority of policies beginning on January 1 following corporations’ open enrollment periods. In addition, the annual enrollment period for Medicare-eligible individuals coincides with this period. It is expected that the majority of enrollments will occur in our second quarter and we have hired additional seasonal benefits advisors to supplement our full-time benefit advisors and incurred higher costs. The associated commission revenue with these new enrollments is deferred until the policy effective date in our third quarter and is spread over the policy period.

Financial Statement Overview

Towers Watson’s fiscal year ends June 30.

The financial statements contained in this quarterly report reflect Condensed Consolidated Balance Sheets as of the end of the third quarter of fiscal year 2013 (March 31, 2013) and as of the end of fiscal year 2012 (June 30, 2012), Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2013 and 2012, Condensed Consolidated Statements of Other Comprehensive Income for the three and nine months ended March 31, 2013 and 2012, Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2013 and 2012 and a Condensed Consolidated Statement of Changes in Stockholders’ Equity for the nine months ended March 31, 2013.

Shown below are Towers Watson’s top five markets based on percentage of consolidated revenue for the nine months ended March 31, 2013 and the fiscal years ended June 30, 2012 and 2011.

 

     Nine Months Ended     Fiscal Year  
     March 31, 2013     2012     2011  

United States

     51     48     49

United Kingdom

     22        23        22   

Canada

     6        6        6   

Germany

     5        5        4   

Netherlands

     2        3        3   

We derive the majority of our revenue from fees for consulting services, which generally are billed at standard hourly rates and expenses, which we refer to as time and expense, or on a fixed-fee basis. Management believes the approximate percentages for time and expense and fixed-fee engagements are 60% and 40%, respectively. Clients are typically invoiced on a monthly basis with revenue generally recognized as services are performed. No single client accounted for more than 1% of our consolidated revenues for any of our three most recent fiscal years.

Our most significant expense is compensation to associates, which typically comprises approximately 70% of total costs of providing services. Salaries and employee benefits are comprised of wages paid to associates, related taxes, severance, benefit expenses such as pension, medical and insurance costs, and fiscal year-end incentive bonuses. We compensate our directors and select executives with incentive stock-based compensation plans. When granted, awards are governed by the Towers Watson & Co. 2009 Long Term Incentive Plan, which provides for the awards to be valued at their grant date fair value which is amortized over the expected term of the awards, generally three years. We also have non-cash stock based compensation related to a plan assumed in the Merger in fiscal year 2010 and a plan assumed in the acquisition of Extend Health in fiscal year 2012.

Professional and subcontracted services represent fees paid to external service providers for employment, marketing and other services. For the three most recent fiscal years, approximately 30 to 50% of the professional and subcontracted services were directly incurred on behalf of clients and were reimbursed by them, with such reimbursements being included in revenue. For the nine months ended March 31, 2013, approximately 35% of professional and subcontracted services represent these reimbursable services.

 

26


Table of Contents

Occupancy includes expenses for rent and utilities, as well as the net reduction to rent related to the amortization of acquired favorable and unfavorable lease agreements.

General and administrative expenses include legal, marketing, human resources, finance, research, technology support, supplies, telephone and other costs to operate office locations as well as professional fees and insurance, including premiums on excess insurance and losses on professional liability claims, non-client-reimbursed travel by associates, publications and professional development. This line item also includes miscellaneous expenses, including gains and losses on foreign currency transactions.

Depreciation and amortization includes the depreciation of fixed assets and amortization of intangible assets and internally-developed software.

Transaction and integration expenses include fees and charges associated with the Merger and with our other acquisitions. Transaction and integration expenses principally consist of integration consultants, contract termination fees, as well as legal, accounting, marketing, and information technology integration expenses.

Critical Accounting Policies and Estimates

There are no material changes from the Critical Accounting Policies and Estimates as previously disclosed in our 2012 Annual Report on Form 10-K, filed on August 29, 2012.

 

27


Table of Contents

Results of Operations

The table below sets forth our condensed consolidated statements of operations, on a historical basis, and data as a percentage of revenue for the period indicated:

Condensed Consolidated Statements of Operations

(Thousands of U.S. dollars)

(Unaudited)

 

     Three Months Ended March 31,     Nine Months Ended March 31,  
     2013     2012     2013     2012  

Revenue

   $ 940,967        100   $ 901,516        100   $ 2,721,461        100   $ 2,591,577        100
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Costs of providing services:

                

Salaries and employee benefits

     564,368        60     544,599        60     1,657,806        61     1,577,375        61

Professional and subcontracted services

     63,225        7     69,644        8     190,921        7     212,665        8

Occupancy

     35,418        4     38,987        4     110,003        4     107,047        4

General and administrative expenses

     82,273        9     79,263        9     251,963        9     214,359        8

Depreciation and amortization

     43,777        5     38,729        4     133,049        5     111,884        4

Transaction and integration expenses

     12,328        1     21,411        2     30,753        1     65,221        3
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     801,389        85     792,633        88     2,374,495        87     2,288,551        88
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     139,578        15     108,883        12     346,966        13     303,026        12

Income (loss) from affiliates

     —          —       167        —       (56     —       335        —  

Interest income

     613        —       784        —       2,118        —       2,942        —  

Interest expense

     (3,483     —       (313     —       (10,043     —       (6,808     —  

Other non-operating income

     12        —       724        —       5,060        —       8,870        —  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     136,720        15     110,245        12     344,045        13     308,365        12

Provision for income taxes

     41,875        4     41,199        5     110,807        4     113,622        4
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income before non-controlling interests

     94,845        10     69,046        8     233,238        9     194,743        8

Less: Net (loss) income attributable to non-controlling interests

     (71     —       812        —       (2,695     —       (134     —  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to controlling interests

   $ 94,916        10   $ 68,234        8   $ 235,933        9   $ 194,877        8
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Results of Operations for the Three and Nine Months Ended March 31, 2013

Compared to the Three and Nine Months Ended March 31, 2012

Revenue

Revenue for the three months ended March 31, 2013 was $941.0 million, an increase of $39.5 million, or 4%, compared to $901.5 million for the three months ended March 31, 2012. Revenue for the nine months ended March 31, 2013 was $2.7 billion, an increase of $129.9 million, or 5%, compared to $2.6 billion for the nine months ended March 31, 2012. Our newest segment, Exchange Solutions, contributed 3% to our total revenue growth in the third quarter and 2% for the nine months ended March 31, 2013. Our Benefits and Risk and Financial Services segments experienced constant currency revenue growth in the third quarter and in the nine months ended March 31, 2013 compared to fiscal year 2012. This growth was driven by economic and regulatory changes. On a constant currency basis, which excludes the effects of currency, revenue increased 5.5% for the third quarter of fiscal 2013 compared to the third quarter of fiscal 2012. On a constant currency basis, revenue increased 6% for the nine months ended March 31, 2013 compared to the nine months ended March 31, 2012.

The average exchange rate used to translate our revenues earned in British pounds sterling was 1.5516 for the third quarter of fiscal 2013 compared to 1.5933 for the third quarter of fiscal year 2012, and the average exchange rate used to translate our revenues earned in Euros was 1.3207 for the third quarter of fiscal year 2013 compared to 1.3667 for the third quarter of fiscal 2012. Constant currency is calculated by translating prior year revenue at the current year average exchange rate.

 

28


Table of Contents

A comparison of segment revenue for the three months ended March 31, 2013, as compared to the three months ended March 31, 2012, is as follows:

 

   

Benefits revenue was $523.5 million for the third quarter of fiscal year 2013 compared to $520.1 million for the third quarter of fiscal year 2012, an increase of 1%. On a constant currency basis, our Benefits segment revenue increased 1.5% due to increased project work across all lines of business. We experienced 1% constant currency revenue growth in our Retirement business revenue, which makes up a majority of the segment. The revenues in the Americas were flat due to a strong prior year comparable but we continue to see bulk lump sum project work. Our Technology and Administration Solutions business experienced 7% revenue growth due to new client work. Our International business experienced an 8% decline in revenue in the Americas and in EMEA. In the America’s our Health and Group Benefits business experienced 5% growth against a strong fiscal year 2012 comparable.

 

   

Risk and Financial Services revenue was $225.4 million for the third quarter of fiscal year 2013 compared to $219.7 million for the third quarter of fiscal year 2012, an increase of 3%. On a constant currency basis, our Risk and Financial Services segment revenue increased 4%, led by growth in the Americas and EMEA. Our Risk Consulting and Software business decreased by 3%. The Americas revenue was flat and EMEA and Asia Pacific revenues decreased due to client demand as clients continue to be cautious with discretionary spending. Our Investment business had 13% revenue growth this quarter in all regions and was especially strong in EMEA due to increased project work and performance fees. Our brokerage business had 12% revenue growth on a constant currency basis. The January renewals went well with some new contracts and favorable rates.

 

   

Talent and Rewards revenue was $124.9 million for the third quarter of fiscal year 2013, compared to $131.1 million for the third quarter of fiscal year 2012, a 5% decrease. On a constant currency basis, Talent and Rewards revenue experienced a 4% decrease. Rewards, Talent and Communication revenue, which is primarily project oriented, declined by 8%. Data, Surveys and Technology business revenue declined by 3%. The environment continues to be challenging as client discretionary spending continues to be tight. Our Executive Compensation business had 2% revenue growth led by EMEA. This growth was due to increased regulation and governance activity in the EMEA and Asia Pacific regions, particularly in China.

 

   

Exchange Solutions revenue was $30.6 million for the third quarter of fiscal year 2013, net of a $0.5 million acquisition accounting adjustment. As our newest segment, Exchange Solutions contributed 3.4% to the Company’s total revenue growth for the third quarter of fiscal year 2013 compared to the third quarter of 2012. We generate revenue from the commissions we receive from insurance carriers for enrolling individuals into their health plans. This revenue increases as the number of enrolled members grows. Included in our revenue for the third quarter of fiscal year 2013 are commissions earned from calendar year 2012 and previous years enrollments. We had a very successful enrollment period for January 1 effective policies, during which we enrolled three times the number of new members compared to Extend Health’s historical results for the past two comparable enrollment seasons. These results indicate the scalability of the process and the technology.

A comparison of segment revenue for the nine months ended March 31, 2013, compared to the nine months ended March 31, 2012, is as follows:

 

   

Benefits revenue increased 3% and was $1.5 billion for the first nine months of fiscal year 2013 compared to $1.5 billion for the first nine months of fiscal year 2012. On a constant currency basis, Benefits revenue increased 5% due to increased project work across all lines of business. The 4% increase in our Retirement business revenue, which makes up a majority of the segment, was driven by 7% revenue growth in the Americas, primarily due to the bulk lump sum projects. We expect a lower volume of bulk lump sum projects in the fourth quarter. The 1% increase in revenue in EMEA was due to an increase in auto-enrollment project activity in the U.K. We expect auto-enrollment work to continue, but the general business environment in the U.K. continues to be challenging. Our Technology and Administration Solutions business experienced 7% revenue growth. The growth in EMEA was driven by new administration work, and the growth in the Americas was due in part to call center support for the bulk lump sum projects. Our International business experienced 2% revenue growth. This group helps to address the issues multinationals face in their compensation and benefit programs. Our Health and Group Benefits business experienced 4% growth and our pipeline continues to look solid. We expect our Benefits segment to show modest growth in all four lines of business.

 

   

Risk and Financial Services revenue increased 1% and was $625.4 million for the first nine months of fiscal year 2013 compared to $618.9 million for the first nine months of fiscal year 2012. Risk and Financial Services revenue increased 2% on a constant currency basis. Our lines of business experienced mixed results with growth in all geographies. Our Risk Consulting and Software business declined 1%, principally in EMEA, as discretionary spending continues to tighten. In addition, it appears likely that the timeline for European regulators to implement Solvency II will slip beyond 2014 and related project work may not reappear for some time. Our Investment business had 9% constant currency growth led by EMEA, due to an increase in project work and performance fees. Our Brokerage revenue increased 1% on a constant currency basis. The January renewals went well with some new contracts and favorable rates. Overall, we expect Risk and Financial Services to continue to show modest growth in the fourth quarter.

 

29


Table of Contents
   

Talent and Rewards revenue remained consistent and was $441.3 million for the first nine months of fiscal year 2013 compared to $440.1 million for the first nine months of fiscal year 2012. Our Talent and Rewards segment experienced 2% constant currency revenue growth. Our Executive Compensation business had 6% constant currency revenue growth led by EMEA. This growth was due to increased regulation and governance activity demand in all regions, particularly in Europe. Rewards, Talent and Communication, which is primarily project oriented, decreased 2% compared to the prior year due to tightening discretionary spending. Data, Surveys and Technology business revenue increased 2%. The third and fourth quarters of the fiscal year are generally seasonally slower.

 

   

Exchange Solutions revenue was $60.3 million for the first nine months of fiscal year 2013. As our newest segment, Exchange Solutions contributed 2.3% to the Company’s total revenue growth for the nine months ended March 31, 2013 compared to the nine months ended March 31, 2012. Exchange Solutions operates the largest private Medicare insurance exchange in the United States. Our core solution enables employers to transition their retirees to individual, defined contribution health plans at an annual cost that the employer controls. We generate revenue from the commissions we receive from insurance carriers for enrolling individuals into their health plans. This revenue increases as the number of enrolled members grows. We had a very successful enrollment period for January 1 effective policies, during which we enrolled three times the number of new members compared to Extend Health’s historical results for the past two comparable enrollment seasons. As a result of acquisition accounting, we will not realize $15 million ($12 million related to fiscal year 2013) of deferred revenue associated with cash received for commissions for policies placed prior to the acquisition, as there is no subsequent performance obligation.

Salaries and Employee Benefits

Salaries and employee benefits were $564.4 million for the third quarter of fiscal year 2013, an increase of $19.8 million, or 4%, compared to $544.6 million for the third quarter of fiscal year 2012. On a constant currency basis, salaries and employee benefits increased by 5%. For the third quarter of fiscal year 2013, our salary expense increase was driven by an increase in base salary of $13.0 million attributable to a 6% increase in headcount, our annual increase in base salary and the impact of foreign currency translation. Our acquisition in the fourth quarter of fiscal year 2012 of Extend Health accounted for 2.5% of our headcount increase and our EMEA and APAC operations accounted for 2.8% of our headcount increase as of March 31, 2013, compared to March 31, 2012. Our discretionary annual bonus is based on pre-bonus profitability and fluctuates based on the operating results of the Company, and as a result, our bonus expense for the third quarter of fiscal year 2013 increased by $7.0 million compared to the third quarter of fiscal year 2012. The $3.7 million increase in our pension expense was due to decreases in discount rates. Stock-based compensation decreased $8.9 million in the current quarter, primarily due to a $5.3 million decrease in expense we recorded to true-up our forfeiture estimate for our final vesting of the restricted stock units issued to employees of Towers Perrin in the Merger. The remaining decrease is the result of no compensation expense recorded this quarter compared to the same quarter in fiscal year 2012, as the service period ended upon the final vesting of these restricted stock units on January 1, 2013. As a percentage of revenue, salaries and employee benefits remained consistent and was 60% for the third quarter of fiscal years 2013 and 2012.

Salaries and employee benefits were $1.7 billion for the first nine months of fiscal year 2013 compared to $1.6 billion for the first nine months of fiscal year 2012, an increase of $80.4 million, or 5%. On a constant currency basis, salaries and employee benefits increased by 7%. This increase was primarily driven by an increase in base salary of $66.7 million attributed to a 6% increase in headcount and an annual increase in base salary. Our discretionary annual bonus is based on pre-bonus profitability and fluctuates based on the operating results of the Company, and as a result, our bonus expense for the first nine months of fiscal year 2013 increased by $6.4 million compared to the first nine months of fiscal year 2012. The $11.2 million increase in our pension expense was due to decreases in discount rates. Stock-based compensation decreased $22.0 million in the current year, primarily due to decreases in expense related to the restricted stock units issued to employee of Towers Perrin in the Merger. We use the graded-vesting method of recording expense related to the restricted stock units, which results in higher expense earlier in the service period. The service period ended January 1, 2013 when the final shares vested, resulting in no expense in the third quarter of fiscal year 2013 compared to the prior fiscal year. In addition, we recorded a $5.3 million reduction in compensation expense when we recorded actual forfeitures of 11% compared to our 10% estimated forfeiture rate. These decreases were partially offset by an increase in non-cash stock-based compensation from the stock option plan that we assumed when we acquired Extend Health in May 2012. As a percentage of revenue, salaries and employee benefits remained consistent and was 61% for the first nine months of fiscal year 2013 and 2012.

Professional and Subcontracted Services

Professional and subcontracted services for the third quarter of fiscal year 2013 was $63.2 million, compared to $69.6 million for the third quarter of fiscal year 2012, a decrease of $6.4 million, or 9%. Our external service provider fees decreased by $5.9 million. In fiscal year 2012, we contracted with these service providers to supplement our day-to-day operations. In fiscal year 2013, our telecommunication, video conferencing, and internet services have been managed by our in-house information technology department and these expenses are classified in general and administrative expenses. In addition, pass-through expenses, which are reimbursable under our contracts, decreased by $2.8 million. As a percentage of revenue, professional and subcontracted services decreased to 7% for the third quarter of fiscal year 2013 from 8% in the third quarter of fiscal year 2012.

 

30


Table of Contents

Professional and subcontracted services for the first nine months of fiscal year 2013 were $190.9 million, compared to $212.7 million for the first nine months of fiscal year 2012, a decrease of $21.7 million, or 10%. Our external service provider fees decreased by $19.3 million due to a shift in the management of our telecommunication, video conferencing, and internet services to our in-house information technology department; these expenses are classified in general and administrative expenses. In addition, pass-through expenses, which are reimbursable under our contracts, decreased by $5.4 million. As a percentage of revenue, professional and subcontracted services decreased to 7% for the first nine months of fiscal year 2013 compared to 8% for the first nine months of fiscal year 2012.

Occupancy

Occupancy expense for the third quarter of fiscal year 2013 was $35.4 million, compared to $39.0 million for the third quarter of fiscal year 2012, a decrease of $3.6 million, or 9%. The decrease was due to lower rent expense. Occupancy expense for the first nine months of fiscal year 2013 was $110.0 million, compared to $107.0 million for the first nine months of fiscal year 2012, an increase of $3.0 million, or 3%. The increase was due to higher utilities, a decrease in sublease income and lower tenant improvement allowances. As a percentage of revenue, occupancy expense was 4% for the three and nine months ended March 31, 2013 and 2012.

General and Administrative

General and administrative expenses for the third quarter of fiscal year 2013 was $82.3 million, compared to $79.3 million for the third quarter of fiscal year 2012, an increase of $3.0 million, or 4%. General and administrative expenses for the first nine months of fiscal year 2013 was $252.0 million, compared to $214.4 million for the first nine months of fiscal year 2012, an increase of $37.6 million, or 18%. Our professional liability expense increased $11.0 million and $26.7 million in our third quarter and in the nine months ended March 31, 2013 compared to 2012, respectively, due primarily to reductions in prior year IBNR reserves, as well as increases in our current legal reserves. We also experienced an increase of $12.0 million in our telecommunications, video conferencing and internet expenses for the first nine months of fiscal year 2013 compared to 2012, respectively. These expenses were classified in professional and subcontracted services in fiscal year 2012 as we previously contracted with an external service provider for these services. In addition, our newest segment Exchange Solutions was formed in the fourth quarter of fiscal year 2012, contributing to higher general and administrative expenses in fiscal year 2013. As a percentage of revenue, general and administrative expenses were 9% for the three and nine months ended March 31, 2013, compared to 9% and 8% for the three and nine months ended March 31, 2012, respectively.

Depreciation and Amortization

Depreciation and amortization expense for the third quarter of fiscal year 2013 was $43.8 million, compared to $38.7 million for the third quarter of fiscal year 2012, an increase of $5.0 million, or 13%. Depreciation and amortization expense for the first nine months of fiscal year 2013 was $133.0 million, compared to $111.9 million for the first nine months of fiscal year 2012, an increase of $21.2 million, or 19%. The increase is partially due to the amortization of intangibles related to our acquisition of Extend Health in the fourth quarter of fiscal year 2012. In addition, we accelerated amortization for a software application that we acquired in the Merger, as management determined that its use would be primarily discontinued in the next two to three years. A portion of the increase is also attributable to increased depreciation on the computer hardware was placed in service in fiscal year 2011 and 2012. As a percentage of revenue, depreciation and amortization expenses were 5% and 4% for three and nine months ended March 31, 2013 and 5% and 4% for the three and nine months ended March 31, 2012, respectively.

Transaction and Integration

Transaction and integration expense for the third quarter of fiscal year 2013 was $12.3 million, compared to $21.4 million for the third quarter of fiscal year 2012, a decrease of $9.1 million, or 42%. Transaction and integration expense for the first nine months of fiscal year 2013 was $30.8 million, compared to $65.2 million for the first nine months of fiscal year 2012, a decrease of $34.5 million, or 53%. The decrease was principally due to a reduction in expenses in the third quarter and first nine months of fiscal year 2013 as information technology integration projects that were ongoing in fiscal year 2012 are close to completion. As a percentage of revenue, transaction and integration expenses were 1% and 2% for the three and nine months ended March 31, 2013 and 1% and 3% for the three and nine months ended March 31, 2012, respectively.

Provision for Income Taxes

Provision for income taxes for the three months ended March 31, 2013 was $41.9 million, compared to $41.2 million for the three months ended March 31, 2012. The effective tax rate was 30.6% for the third quarter of fiscal year 2013 and 37.4% for the third quarter of fiscal year 2012. The prior year effective tax rate includes increases to uncertain tax positions of 1.7%. The current year effective tax rate is lower primarily due to a tax benefit on the effective settlement of uncertain tax positions of 2.3% and tax benefits from tax return true ups of 2.4% in the third quarter of fiscal year 2013. Towers Watson records a tax benefit on net operating loss carryovers and net deferred tax assets only if it is more likely than not that a benefit will be realized.

 

31


Table of Contents

Provision for income taxes for the first nine months of fiscal year 2013 was $110.8 million with an effective tax rate of 32.2%, compared to $113.6 million with an effective tax rate of 36.8% for the first nine months of fiscal year 2012. The change in the effective tax rate is primarily due to current year income tax benefits resulting from legal entity restructurings of 1.4% and income tax benefits on the release of uncertain tax positions of 1.2% resulting from the settlement of an IRS examination during the quarter. The change in effective rate is also due to prior year increases resulting from the establishment of valuation allowances in foreign jurisdictions of 0.6% and increases in uncertain tax positions of 1.0% in the nine months ended March 31, 2012.

Net Income Attributable to Controlling Interests

Net income attributable to controlling interests for the three months ended March 31, 2013 was $94.9 million, compared to $68.2 million for the three months ended March 31, 2012. Net income attributable to controlling interests for the first nine months of fiscal year 2013 was $235.9 million compared to $194.9 million for the first nine months of fiscal year 2012.

Diluted Earnings Per Share

Diluted earnings per share for the third quarter of fiscal year 2013 was $1.34, compared to $0.95 for the third quarter of fiscal year 2012. Diluted earnings per share for the first nine months of fiscal year 2013 was $3.29, compared to $2.68 for the first nine months of fiscal year 2012.

Liquidity and Capital Resources

Our most significant sources of liquidity are funds generated by operating activities, available cash and cash equivalents, and our credit facility. Consistent with our liquidity position, management considers various alternative strategic uses of cash reserves including acquisitions, dividends and stock buybacks, or any combination of these options.

We believe that we have sufficient resources to fund operations beyond the next 12 months. The key variables that we manage in response to current and projected capital resource needs include credit facilities and short-term borrowing arrangements, working capital and our stock repurchase program.

Our cash and cash equivalents at March 31, 2013 totaled $472.7 million, compared to $478.2 million at June 30, 2012. The decrease in cash from June 30, 2012 to March 31, 2013 was primarily due to contributions to our qualified pension plans; the acceleration of dividend payments for calendar year 2013 in December 2012; and higher repayments under our credit facility.

Our cash and cash equivalents balance includes $49.5 million from the consolidated balance sheets of PCIC and SMIC, which is available for payment of professional liability claims reserves. As a result, we have a net $423.2 million of cash that is available for our general use.

Our restricted cash at March 31, 2013 totaled $178.3 million, compared to $171.4 million at June 30, 2012, of which $173.5 million at March 31, 2013 was held on behalf of our reinsurance clients to pay premiums or claims and an additional $4.8 million was held for payment of health and welfare premiums on behalf of our clients.

Our non-U.S. operations are substantially self-sufficient for their working capital needs. As of March 31, 2013, $393.6 million of Towers Watson’s total cash and cash equivalents balance of $472.7 million was held outside of the United States. Should we require more capital in the U.S. than is generated by our U.S. operations, we may decide to make additional borrowings under our Senior Credit Facility, repatriate funds held in foreign jurisdictions or raise capital in the U.S. through debt or equity issuances. These alternatives could result in higher effective tax rates or increased interest expense. We do not expect restrictions or taxes on repatriation of cash held outside the U.S. to have a material effect on the Company’s overall liquidity, financial condition or results of operations.

During the quarter, we changed our ASC 740, Income Taxes, assertion with respect to our U.K. subsidiary and intend to make a distribution of approximately $165 million by June 30, 2013. We have not recorded income tax expense for this distribution as the estimated additional U.S. tax cost is expected to be insignificant due to available foreign tax credits from the dividend equivalent to the U.S. statutory tax rate. We have not provided U.S. federal income taxes on undistributed foreign earnings of our other foreign subsidiaries because such earnings are considered indefinitely reinvested outside the United States. It is not practicable to estimate the U.S. federal income tax liability that might be payable if such earnings are not reinvested indefinitely. If future events, including material changes in estimates of cash, working capital and long-term investment requirements, necessitate that these earnings be repatriated, an additional provision for U.S. income and foreign withholding taxes, net of foreign tax credits, may be necessary.

 

32


Table of Contents

Assets and liabilities associated with non-U.S. entities have been translated into U.S. dollars as of March 31, 2013 at U.S. dollar rates that fluctuate compared to historical periods. As a result, cash flows derived from changes in the consolidated balance sheets include the impact of the change in foreign exchange translation rates.

Events that could change the historical cash flow dynamics discussed above include significant changes in operating results, potential future acquisitions or divestitures, material changes in geographic sources of cash, unexpected adverse impacts from litigation or future pension funding during periods of severe downturn in the capital markets.

Cash Flows From Operating Activities.

Cash flows from operating activities was $286.5 million for the first nine months of fiscal year 2013 compared to cash flows from operating activities of $158.5 million for the first nine months of fiscal year 2012. This increase is primarily from an increase in net income before non-controlling interests and increased cash collections from client receivables offset by contributions to our qualified pension plans.

The allowance for doubtful accounts decreased $4.6 million from June 30, 2012 to March 31, 2013. The number of days of sales outstanding decreased to 79 at March 31, 2013, compared to 90 at June 30, 2012.

Cash Flows Used in Investing Activities.

Cash flows used in investing activities for the first nine months of fiscal year 2013 were $91.1 million, compared to $49.8 million of cash flows used in investing activities for the first nine months of fiscal year 2012. The additional cash used in investing activities reflects smaller redemptions and greater purchases of available-for-sale securities.

Cash Flows Used in Financing Activities.

Cash flows used in financing activities for the first nine months of fiscal 2013 were $187.6 million, compared to cash flows used in financing activities of $187.8 million for the first nine months of fiscal year 2012. Cash flows used in financing activities remained consistent in fiscal year 2013 compared to fiscal year 2012; however, the mix of cash inflows and outflows changed. We had higher borrowings under our Senior Credit Facility offset by higher repayments. We had decreased repurchases of common stock offset by increased and accelerated dividend payments of $32.5 million to shareholders during December 2012 for dividends otherwise potentially payable in January, April, July and October 2013 in anticipation of an increase on the tax rate on dividend income.

During the nine months ended March 31, 2013, the average outstanding balance on our Senior Credit Facility was $248.4 million and the largest outstanding balance was $365.9 million.

Capital Commitments

Capital expenditures were $66.6 million for the first nine months of fiscal year 2013. Anticipated commitments of capital funds are estimated at $20 million for the remainder of fiscal year 2013. We expect cash from operations to adequately provide for these cash needs.

Dividends

During the three months ended December 31, 2012, our board of directors approved the payment of a quarterly cash dividend in the amount of $0.115 per share which was paid in December 2012. Additionally, the board of directors declared an acceleration for calendar year 2013 of dividends otherwise payable in April 2013, July 2013 and October 2013. The $0.345 per share accelerated dividend was paid in December 2012. Since all dividends that would have been otherwise payable in calendar year 2013 were paid in December 2012, there were no dividend payments for the three months ended March 31, 2013. Total dividends paid in the nine months ended March 31, 2013 and 2012 were $48.1 million and $19.4 million, respectively.

Off-Balance Sheet Arrangements and Contractual Obligations

Operating Leases. We lease office space, furniture, cars and selected computer equipment under operating lease agreements with terms typically ranging from one to ten years. We have determined that there is not a large concentration of leases that will expire in any one fiscal year. Consequently, management anticipates that any increase in future rent expense on leases will be mainly market driven. Intangible assets and liabilities were recognized for the difference between the contractual cash obligations and the estimated market rates at the time of the acquisitions. The resulting intangibles amortize to rent expense but do not impact our contractual cash obligations.

Pension Contributions. Remaining contributions to our various pension plans for fiscal year 2013 are projected to be approximately $ 18.4 million.

 

33


Table of Contents

Uncertain Tax Positions. We have liabilities for uncertain tax positions under ASC 740. The expected settlement period for the $37.5 million liability, which excludes interest and penalties, cannot be reasonably estimated because it depends on the timing and possible outcomes of tax examinations with various tax authorities.

It is reasonably possible that during the next 12 months the Company’s liability for uncertain tax positions may change by a significant amount. The Company may settle certain tax examinations or have lapses in statute of limitations for different amounts than the Company has accrued. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more likely than not standard if such positions are not upheld. Conversely, the Company could settle positions with the tax authorities for amounts lower than have been accrued or extinguish a position through payment. The Company believes the outcomes which are reasonably possible within the next 12 months may result in a reduction in the liability for uncertain tax positions in the range of approximately $21.0 million to $22.0 million, excluding interest and penalties.

Indebtedness

Towers Watson Senior Credit Facility

On November 7, 2011, Towers Watson and certain subsidiaries entered into a five-year, $500 million revolving credit facility, which amount may be increased by an aggregate amount of $250 million, subject to the satisfaction of customary terms and conditions, with a syndicate of banks (the “Senior Credit Facility”), replacing a previous facility due to expire in December 2012. Borrowings under the Senior Credit Facility bear interest at a spread to either LIBOR or the Prime Rate. During the nine months ended March 31, 2013, the weighted-average interest rate on the Senior Credit Facility was 1.49%. We are charged a quarterly commitment fee, currently 0.175% of the Senior Credit Facility, which varies with our financial leverage and is paid on the unused portion of the Senior Credit Facility. Obligations under the Senior Credit Facility are guaranteed by Towers Watson and all of its domestic subsidiaries (other than Professional Consultants Insurance Company (“PCIC”), a majority-owned captive insurance company, and Stone Mountain Insurance Company (“SMIC”), a wholly-owned captive insurance company).

The Senior Credit Facility contains customary representations and warranties and affirmative and negative covenants. The Senior Credit Facility requires Towers Watson to maintain certain financial covenants that include a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Leverage Ratio (which terms in each case are defined in the Senior Credit Facility). In addition, the Senior Credit Facility contains restrictions on the ability of Towers Watson to, among other things, incur additional indebtedness; pay dividends; make distributions; create liens on assets; make acquisitions; dispose of property; engage in sale-leaseback transactions; engage in mergers or consolidations, liquidations and dissolutions; engage in certain transactions with affiliates; and make changes in lines of businesses. As of March 31, 2013, we were in compliance with our covenants.

As of March 31, 2013, Towers Watson had borrowings of $135.0 million outstanding under the Senior Credit Facility.

Letters of Credit under the Senior Credit Facility

As of March 31, 2013, Towers Watson had standby letters of credit totaling $24.9 million associated with our captive insurance companies in the event that we fail to meet our financial obligations. Additionally, Towers Watson had $1.7 million of standby letters of credit covering various other existing or potential business obligations. The aforementioned letters of credit are issued under the Senior Credit Facility, and therefore reduce the amount that can be borrowed under the Senior Credit Facility by the outstanding amount of these standby letters of credit.

Term Loan Agreement Due June 2017

On June 1, 2012, the Company entered into a five-year $250 million amortizing term loan facility (“the Term Loan”) with a consortium of banks. The interest rate on the term loan is based on the Company’s choice of one, three or six month LIBOR plus a spread of 1.25% to 1.75%, or alternatively the bank base rate plus 0.25% to 0.75%. The spread to each index is dependent on the Company’s consolidated leverage ratio. The weighted-average interest rate on the Term Loan during the nine months ended March 31, 2013 was 1.47%. The Term Loan amortizes at a rate of $6.25 million per quarter, beginning in September 2013, with a final maturity date of June 1, 2017. The Company has the right to prepay a portion or all of the outstanding Term Loan balance on any interest payment date without penalty.

This agreement contains substantially the same terms and conditions as our Senior Credit Facility, including guarantees from all of the domestic subsidiaries of Towers Watson (other than PCIC and SMIC). The Company entered into the Term Loan as part of the financing of our acquisition of Extend Health (see Note 2).

 

34


Table of Contents

Non-U.S. GAAP Measures

In order to assist readers of our financial statements in understanding the core operating results that the Company’s management uses to evaluate the business and for financial planning, we present (1) Adjusted EBITDA, (2) Adjusted Net Income Attributable to Controlling Interests, and (3) Adjusted Diluted Earnings Per Share (which are all non-U.S. GAAP measures), to eliminate the effect of acquisition-related expenses from the financial results of our operations. We use Adjusted Net Income Attributable to Controlling Interests (the numerator) for the purpose of calculating Adjusted Diluted Earnings Per Share. The Company believes that Adjusted EBITDA and Adjusted Diluted Earnings Per Share are relevant and useful information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating results.

Since the Merger in January 2010, we have incurred significant acquisition-related expenses related to our merger and integration activities necessary to combine Watson Wyatt and Towers Perrin. These acquisition-related expenses include transaction and integration costs, severance costs, non-cash charges for amortization of intangible assets and merger-related stock-based compensation costs from the issuance of merger-related restricted shares. Included in our acquisition-related transaction and integration costs are integration consultant fees and legal, accounting, marketing and information technology integration expenses. We expect that during the first three years following the merger, these activities and the related expenses will be incurred and be significant, although amortization will continue over the estimated useful lives of the related intangibles. We consider Adjusted EBITDA and Adjusted Diluted Earnings Per Share to be important financial measures, which we use to internally evaluate and assess our core operations, and benchmark our operating results against our competitors. We use Adjusted EBITDA to evaluate and measure our performance-based compensation plans. Adjusted EBITDA and Adjusted Diluted Earnings Per Share are important in illustrating what our operating results would have been had we not incurred these acquisition-related expenses.

We define Adjusted EBITDA as net income before non-controlling interests adjusted for provision for income taxes, interest, net, depreciation and amortization, transaction and integration expenses, stock-based compensation, and other non-operating income. These non-U.S. GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measure of other companies. Non-U.S. GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our financial statements.

 

35


Table of Contents

Reconciliation of Adjusted EBITDA to net income before non-controlling interests, Adjusted Net Income Attributable to Controlling Interests to net income attributable to controlling interests and Adjusted Diluted Earnings Per Share to diluted earnings per share are included in the tables below.

 

     Three Months Ended  
     March 31,  
     2013     2012  
     (in thousands)  

Reconciliation of net income before non-controlling interests to

    

Adjusted EBITDA is as follows:

    

Net income before non-controlling interests

   $ 94,845      $ 69,046   

Provision for income taxes

     41,875        41,199   

Interest, net

     2,870        (471

Depreciation and amortization

     43,777        38,729   

Transaction and integration expenses

     12,328        21,411   

Stock-based compensation (a)

     (4,236     4,507   

Change in accounting method for pension (b)

     —          6,237   

Other non-operating income (c)

     (12     (891
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 191,447      $ 179,767   
  

 

 

   

 

 

 

 

     Nine Months Ended  
     March 31,  
     2013     2012  
     (in thousands)  

Reconciliation of net income before non-controlling interests to

    

Adjusted EBITDA is as follows:

    

Net income before non-controlling interests

   $ 233,238      $ 194,743   

Provision for income taxes

     110,807        113,622   

Interest, net

     7,925        3,866   

Depreciation and amortization

     133,049        111,884   

Transaction and integration expenses

     30,753        65,221   

Stock-based compensation (a)

     8,620        26,659   

Change in accounting method for pension (b)

     —          6,237   

Other non-operating income (c)

     (5,004     (9,205
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 519,388      $ 513,027   
  

 

 

   

 

 

 

 

(a) Stock-based compensation is included in salary and employee benefits expense and relates to Towers Watson Restricted Class A shares held by our current associates which were awarded to them in connection with the Merger and other acquisitions.
(b) The Company had a net impact of $6.2 million during the prior year as a result of the cumulative effect of the change in accounting method of $9.5 million offset by a reduction in net periodic cost of $3.3 million.
(c) Other non-operating income includes income from affiliates and other non-operating income.

 

36


Table of Contents

A reconciliation of net income attributable to controlling interests, as reported under generally accepted accounting principles, to adjusted net income attributable to controlling interests, and of diluted earnings per share as reported under generally accepted accounting principles to adjusted diluted earnings per share is as follows:

 

     Three Months Ended  
     March 31,  
     2013     2012  
    

(In thousands, except share and

per share amounts)

 

Net income attributable to controlling interests

   $ 94,916      $ 68,234   

Adjusted for certain Merger-related items (d),(e):

    

Amortization of intangible assets

     13,455        11,443   

Transaction and integration expenses including severance

     8,552        13,701   

Stock-based compensation (f)

     (2,939     2,911   

Change in accounting method for pension

     —          4,065   
  

 

 

   

 

 

 

Adjusted net income attributable to controlling interests

   $     113,984      $     100,354   
  

 

 

   

 

 

 

Weighted average shares of common stock — diluted (000)

     71,076        71,953   
  

 

 

   

 

 

 

Earnings per share — diluted, as reported

   $ 1.34      $ 0.95   

Adjusted for certain Merger-related items:

    

Amortization of intangible assets

     0.18        0.16   

Transaction and integration expenses including severance

     0.12        0.18   

Stock-based compensation

     (0.04     0.04   

Change in accounting method for pension

     —          0.06   
  

 

 

   

 

 

 

Adjusted earnings per share — diluted

   $ 1.60      $ 1.39   
  

 

 

   

 

 

 

 

     Nine Months Ended  
     March 31,  
     2013      2012  
     (In thousands, except share and
per share amounts)
 

Net income attributable to controlling interests

   $ 235,933       $ 194,877   

Adjusted for certain Merger-related items (d),(e):

     

Amortization of intangible assets

     39,950         31,561   

Transaction and integration expenses including severance

     20,795         41,142   

Stock-based compensation (f)

     5,588         17,435   

Change in accounting method for pension

     —           4,065   

Gain on investment in Fifth Quadrant

     —           (1,779

Release of acquisition related liability

     —           (601

Other merger-related tax items

     —           (698
  

 

 

    

 

 

 

Adjusted net income attributable to controlling interests

   $     302,266       $     286,002   
  

 

 

    

 

 

 

Weighted average shares of common stock — diluted (000)

     71,639         72,658   
  

 

 

    

 

 

 

Earnings per share — diluted, as reported

   $ 3.29       $ 2.68   

Adjusted for certain Merger-related items:

     

Amortization of intangible assets

     0.55         0.43   

Transaction and integration expenses including severance

     0.29         0.57   

Stock-based compensation

     0.08         0.24   

Change in accounting method for pension

     —           0.06   

Gain on investment in Fifth Quadrant

     —           (0.03

Release of acquisition related liability

     —           (0.01

Other merger-related tax items

     —           (0.01
  

 

 

    

 

 

 

Adjusted earnings per share — diluted

   $ 4.21       $ 3.93   
  

 

 

    

 

 

 

 

(d) The adjustments to net income attributable to controlling interests and diluted earnings per share of certain Merger-related items are net of tax. In calculating the net of tax amounts, all adjustments were tax effected at the applicable effective tax rate (ETR) for the period, which was 30.6% and 32.2% for the three and nine months ended March 31, 2013, respectively.

 

37


Table of Contents
(e) In periods prior to fiscal 2013 there were significant variances between the interim period effective tax rate (ETR) and the applicable ETR for each merger-related item. For the three months ended March 31, 2012 the adjustments were tax effected at 35.5% for amortization of intangible assets, 36.0% for transaction and integration expenses including severance, 35.4% for stock-based compensation, and 34.8% for change in accounting method for pension. For the nine months ended March 31, 2012 the adjustments were tax effected at 34.8% for amortization of intangible assets, 36.9% for transaction and integration expenses including severance, 34.6% for stock-based compensation, 34.8% for change in accounting method for pension, 28.0% for gain on investment in Fifth Quadrant, and 39.9% for release of acquisition related liability.
(f) Stock-based compensation relates to Towers Watson Restricted Class A shares held by our current associates which were awarded to them in connection with the Merger and other acquisitions.

Risk Management

As a part of our risk management program, we purchase customary commercial insurance policies, including commercial general liability and claims-made professional liability insurance. Our professional liability insurance currently includes a self-insured retention of $1 million per claim, and covers professional liability claims against us, including the cost of defending such claims.

Effective July 1, 2010 through July 1, 2011, Stone Mountain Insurance Company (“SMIC”), a wholly-owned captive insurance company, provided us with $50 million of professional liability insurance coverage per claim and in the aggregate, including the cost of defending such claims, above the $1 million self-insured retention. SMIC secured $25 million of reinsurance coverage from unaffiliated reinsurance companies in excess of the $25 million SMIC retained layer. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies. Because we have a self-insured retention for each claim and because Stone Mountain is wholly-owned by us, our primary errors and omissions risk is borne by Towers Watson or the subsidiary SMIC. As stated above, commencing July 1, 2010, Towers Watson obtained primary insurance for errors and omissions professional liability risks from SMIC on a claims-made basis. SMIC has issued a policy of insurance substantially similar to the policies historically issued by PCIC.

For the policy period beginning July 1, 2011 and ending July 1, 2012, certain changes were made to our professional liability insurance program. These changes remain in-force for the policy period July 1, 2012 and ending July 1, 2013. Our professional liability insurance includes a self-insured retention of $1 million per claim. Towers Watson also retains $10 million in the aggregate above the $1 million self-insured retention per claim. SMIC provides us with $40 million of coverage per claim and in the aggregate, above these retentions. SMIC secured $25 million of reinsurance from unaffiliated reinsurance companies in excess of the $15 million SMIC retained layer. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies. Because of the $1 million self-insured retention per claim and the additional $10 million aggregate retention above, and because Stone Mountain is wholly-owned by us, our primary errors and omissions risk is borne by Towers Watson and the subsidiary SMIC. We reserve for contingent liabilities based on ASC 450, Contingencies, when it is determined that a liability, inclusive of defense costs, is probable and reasonably estimable. The contingent liabilities recorded are primarily developed actuarially.

Before the Merger, Watson Wyatt and Towers Perrin each obtained substantial professional liability insurance from an affiliated captive insurance company, Professional Consultants Insurance Company (“PCIC”). A limit of $50 million per claim and in the aggregate was provided by PCIC subject to a $1 million per claim self-insured retention. PCIC secured reinsurance of $25 million attaching above the $25 million PCIC retained layer. In addition, both legacy companies carried excess insurance from unaffiliated commercial insurance companies above the self-insured retention and the coverage provided by PCIC.

Our ownership interest in PCIC is 72.86% post-Merger. As a consequence, PCIC’s results of operations are consolidated into our results of operations. Although the PCIC insurance policies for Towers Watson’s fiscal year 2010 continue to cover professional liability claims above a $1 million per claim self-insured retention, the consolidation of PCIC will effectively net PCIC’s premium income against our premium expense for the first $25 million of loss above the self-insured retention for each legacy company. Accordingly, the impact of PCIC’s reserve development may result in fluctuations in our earnings. PCIC ceased issuing insurance policies effective July 1, 2010 and at that time entered into a run-off mode of operation. Our shareholder agreements with PCIC could require additional payments to PCIC if development of claims significantly exceeds prior expectations.

We provide for the self-insured retention where specific estimated losses and loss expenses for known claims are considered probable and reasonably estimable. Although we maintain professional liability insurance coverage, this insurance does not cover claims made after expiration of our current policies of insurance. Generally accepted accounting principles require that we record a liability for incurred but not reported (“IBNR”) professional liability claims if they are probable and reasonably estimable, and for which we have not yet contracted for insurance coverage. We use actuarial assumptions to estimate and record our IBNR liability. As of March 31, 2013, we had a $198.6 million IBNR liability balance, net of recoverable receivables of our captive insurance companies. This net liability was $202.2 million as of June 30, 2012. To the extent our captive insurance companies, PCIC and SMIC, expect losses to be covered by a third party, they record a receivable for the amount expected to be recovered. This receivable is classified in other current or other noncurrent assets in our consolidated balance sheet.

Insurance market conditions for us and our industry have varied in recent years, but the long-term trend has been increasing premium cost. Although the market for professional liability insurance is presently reasonably accessible, trends toward higher self-insured retentions, constraints on aggregate excess coverage for this class of professional liability risk and financial difficulties which have,

 

38


Table of Contents

over the past few years, been faced by several longstanding E&O carriers, are anticipated to recur periodically, and to be reflected in our future annual insurance renewals. As a result, we will continue to assess our ability to secure future insurance coverage, and we cannot assure that such coverage will continue to be available in the event of adverse claims experience, adverse loss trends, market capacity constraints or other factors.

In light of increasing litigation worldwide, including litigation against professionals, we have a policy that all client relationships be documented by engagement letters containing specific risk mitigation clauses that were not included in all historical client agreements. Certain contractual provisions designed to mitigate risk may not be legally enforceable in litigation involving breaches of fiduciary duty or certain other alleged errors or omissions, or in certain jurisdictions. We may incur significant legal expenses in defending against litigation.

Disclaimer Regarding Forward-looking Statements

This filing contains a number of “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to the following: following: Note 4 — Goodwill and Intangible Assets; Note 7 — Retirement Benefits; Note 8 — Debt, Commitments and Contingent Liabilities; Note 11 — Restricted Stock; Note 13 — Income Taxes; Management’s Discussion and Analysis of Financial Condition and Results of Operations — Executive Overview; — Critical Accounting Policies and Estimates; the discussion of our capital expenditures; — Off-Balance Sheet Arrangements and Contractual Obligations; — Liquidity and Capital Resources; — Risk Management; and Part II, Item 1 “Legal Proceedings”. You can identify these statements and other forward-looking statements in this filing by words such as “may”, “will”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “intend”, “continue”, or similar words, expressions or the negative of such terms or other comparable terminology. You should read these statements carefully because they contain projections of our future results of operations or financial condition, or state other “forward-looking” information. A number of risks and uncertainties exist which could cause actual results to differ materially from the results reflected in these forward-looking statements. Such factors include but are not limited to:

 

   

general economic and business conditions, including a significant or prolonged economic downturn, that adversely affect us or our clients;

 

   

our continued ability to recruit and retain qualified associates;

 

   

the success of our marketing, client development and sales programs after our acquisitions;

 

   

our ability to maintain client relationships and to attract new clients after our acquisitions;

 

   

declines in demand for our services;

 

   

our ability to reduce our effective tax rate through the restructuring of certain foreign operations of Towers Perrin;

 

   

our ability to make suitable acquisitions and divestitures;

 

   

our ability to integrate acquired businesses into our own business, processes and systems, and achieve the anticipated results;

 

   

the acquisition of Extend Health is not profitable or is not otherwise successfully integrated;

 

   

foreign currency exchange and interest rate fluctuations;

 

   

recent SEC rules concerning compensation consultant independence and disclosure of compensation consultant fees, and the potential impact of losses of clients and associates;

 

   

outcomes of pending or future litigation and the availability and capacity of professional liability insurance to fund the outcome of pending cases or future judgments or settlements;

 

   

our ability to obtain professional liability insurance;

 

   

a significant decrease in the demand for the consulting, actuarial and other services we offer as a result of changing economic conditions or other factors;

 

   

actions by competitors, including public accounting and consulting firms, technology consulting firms, insurance consulting firms and Internet/intranet development firms;

 

   

our ability to achieve cost reductions after acquisitions;

 

   

exposure to liabilities that have not been expressly assumed in our acquisition transactions;

 

39


Table of Contents
   

the ability to successfully address issues surrounding the number of Company shares that will become freely tradable on January 1, 2014;

 

   

potential changes in federal and state health care regulations or future interpretation of existing regulations;

 

   

our newly-acquired Extend Health business fails to maintain good relationships with insurance carriers, becomes dependent upon a limited number of insurance carriers or fails to develop new insurance carrier relationships;

 

   

changes and developments in the health insurance system in the United States;

 

   

our ability to respond to rapid technological changes;

 

   

the level of capital resources required for future acquisitions and business opportunities;

 

   

regulatory developments abroad and domestically that impact our business practice;

 

   

legislative and technological developments that may affect the demand for or costs of our services;

and other factors as discussed under “Risk Factors” in our most recent Annual Report on Form 10-K filed with the SEC, as supplemented in our Quarterly Reports on Form 10-Q. These statements are based on assumptions that may not come true. All forward-looking disclosure is speculative by its nature. The Company undertakes no obligation to update any of the forward-looking information included in this report, whether as a result of new information, future events, changed expectations or otherwise.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Towers Watson is exposed to market risks in the ordinary course of business. These risks include interest rate risk, foreign currency exchange and translation risk.

Interest Rate Risk

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we maintain our portfolio in mainly short term securities that are recorded on the balance sheet at fair value.

Towers Watson’s pension and postretirement plan liabilities and expenses are affected by discount rates that are market-driven. The Company is sensitive to movements in the discount rates, the impact of which are shown in the critical accounting policies and estimates section in our most recent Annual Report on Form 10-K filed with the SEC on August 29, 2012.

Foreign Currency Risk

We consolidate our international subsidiaries by converting them into U.S. dollars in accordance with generally accepted accounting principles of foreign currency translation. The results of operations and our financial position will fluctuate when there is a change in foreign currency exchange rates.

For the nine months ended March 31, 2013, 49% of our revenue was denominated in currencies other than the U.S. dollar, typically in the local currency of our foreign operations. These operations also incur most of their expenses in the local currency. Accordingly, our foreign operations use the local currency as their functional currency and our primary international operations use the British pound sterling, Canadian dollar and the Euro. Our international operations are subject to risks typical of international operations, including, but not limited to, differing economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be adversely impacted by changes in these or other factors. As of March 31, 2013, a uniform 10% strengthening in the value of the U.S. dollar relative to the currencies in which our transactions are denominated would have resulted in a decrease in net income attributable to controlling interests of $23.2 million, or 7%, for the nine months ended March 31, 2013. This theoretical calculation assumes that each exchange rate would change in the same direction relative to the U.S. dollar. This calculation is not indicative of our actual experience in foreign currency transactions.

Foreign exchange rate fluctuations may adversely impact our consolidated financial position as the assets and liabilities of our foreign operations are translated into U.S. dollars in preparing our condensed consolidated balance sheet. Additionally, foreign exchange rate fluctuations may adversely impact our condensed consolidated results of operations as exchange rate fluctuations on transactions denominated in currencies other than our functional currencies result in gains and losses that are reflected in our condensed consolidated statement of operations. Certain of Towers Watson’s foreign subsidiaries, receive revenue (either internal or external) in currencies that differ from their functional currencies. To reduce this variability, Towers Watson may use foreign exchange forward

 

40


Table of Contents

contracts and over-the-counter options to hedge the foreign exchange risk of the forecasted collections for up to a maximum of two years in the future. In certain circumstances, Towers Watson will choose to internally offset currency exposures, where such natural offsets have been identified.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

An evaluation was performed under the supervision and with the participation of our management, including the chief executive officer, or CEO, and chief financial officer, or CFO, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our management, including the CEO and CFO, concluded that our disclosure controls and procedures were effective as of March 31, 2013.

Changes in Internal Control Over Financial Reporting

During the year ended June 30, 2012, we began a phased implementation of a new enterprise resource planning system to be used as our accounting system. During the three months ended March 31, 2013, our new system deployment was completed. The transition to the new information system included a significant effort in the testing of the system prior to deployment, training of associates who are using the system and updating of our internal control process and procedures that were impacted by the deployment. During each phase of the deployment, we tested the results from the system and performed an appropriate level of monitoring of the system’s results. As a result of the deployment of the system, our management updated the system of internal control over the impacted areas.

Limitations on the Effectiveness of Controls

Management, including the CEO and CFO, does not expect that our disclosure controls and procedures will necessarily prevent all error and all fraud. However, management does expect that the control system provides reasonable assurance that its objectives will be met. A control system, no matter how well designed and operated, cannot provide absolute assurance that the control system’s objectives will be met. In addition, the design of such internal controls must take into account the costs of designing and maintaining such a control system. Certain inherent limitations exist in control systems to make absolute assurances difficult, including the realities that judgments in decision-making can be faulty, that breakdowns can occur because of a simple error or mistake, and that individuals can circumvent controls. The design of any control system is based in part upon existing business conditions and risk assessments. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in business conditions or deterioration in the degree of compliance with policies or procedures. As a result, they may require change or revision. Because of the inherent limitations in a control system, misstatements due to error or fraud may occur and may not be detected. Nevertheless, the disclosure controls and procedures are designed to provide reasonable assurance of achieving their stated objectives, and the CEO and CFO have concluded that the disclosure controls and procedures are effective at a reasonable assurance level.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

From time to time, we are a party to various lawsuits, arbitrations or mediations that arise in the ordinary course of business. The disclosure called for by Part II, Item 1, regarding our legal proceedings is incorporated by reference herein from Note 8 “Debt, Commitments and Contingent Liabilities,” of the Notes to the Condensed Consolidated Financial Statements in this Form 10-Q for the quarter ended March 31, 2013.

ITEM 1A. RISK FACTORS.

There are no material changes from risk factors as previously disclosed in our 2012 Annual Report on Form 10-K, filed on August 29, 2012. We urge you to read the risk factors contained in our Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

(c) Issuer Purchases of Equity Securities

The Towers Watson Board has authorized the Company to periodically repurchase shares of common stock under two distinct sets of authority.

The purpose of the first authority is to offset the dilutive effect of issuance of shares under the Company’s equity based compensation plans (“Dilution”). During the third quarter of fiscal year 2010, our Board of Directors approved the repurchase of up to 750,000

 

41


Table of Contents

shares of our Class A Common Stock to offset Dilution. During the first quarter of fiscal 2012, the Board of Directors approved the repurchase of an additional 1,000,000 shares of Class A Common Stock to offset Dilution. As of March 31, 2013, 788,189 shares remained available for repurchase under this authority.

The purpose of the second authority is to purchase shares of the Company’s Class A Common Stock outside of the anti-dilutive authorization. During the second quarter of fiscal year 2011, the Company’s Board of Directors approved the repurchase of up to $100 million of the Company’s Class A Common Stock. During the third quarter of fiscal 2012, the $100 million general repurchase authorization was exhausted, and the Board of Directors approved the repurchase of an additional $150 million of the Company’s Class A Common Stock. As of March 31, 2013, $120.5 million remained available for the repurchase of shares under this authority.

There are no expiration dates for any of these repurchase plans or programs. The table below presents specified information about the Company’s Class A Common Stock repurchases in the third quarter of fiscal year 2013 and the Company’s repurchase plans:

 

Period

   Total
Number of
Shares
Purchased (a)
     Average
Price
Paid per
Share
     Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Plans or
Programs
     Maximum
Number of
Shares that
May Yet Be
Purchased
Under the
Plans or
Programs (b)
 

January 1, 2013 through January 31, 2013 (c)

     166,432       $ 55.34         166,432         2,536,146   

February 1, 2013 through February 28, 2013

     —           —           —           2,536,146   

March 1, 2013 through March 31, 2013

     10,100         66.97         10,100         2,526,046   
  

 

 

       

 

 

    
     176,532            176,532      
  

 

 

       

 

 

    

 

(a) All of the shares of Class A Common Stock repurchased in the third quarter of fiscal year 2013 were repurchased under the $150 million repurchase plan approved by our Board of Directors.
(b) The maximum number of shares that may yet be purchased under our plans includes the remaining shares under our two stock repurchase plans. An estimate of the maximum number of shares under the repurchase of up to $150 million was determined using the closing price of our stock on March 28, 2013, the last trading day of our fiscal quarter, of $69.32.
(c) The total number of shares purchased in January 2013 includes shares that Towers Watson agreed to repurchase in 2010. While Towers Watson made partial payments for these shares in 2010, 2012 and 2013, the shares were not considered repurchased until the final payment was made in January 2013.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

 

42


Table of Contents

ITEM 6. EXHIBITS.

EXHIBIT INDEX

 

Exhibit
Number

  

Description of Exhibit

  10.3    Amended and Restated Towers Watson & Co. 2009 Long Term Incentive Plan.**
  31.1    Certification of the Registrant’s Chief Executive Officer, John J. Haley, pursuant to Rule 13a-14 of the Securities Exchange Act of 1934.*
  31.2    Certification of the Registrant’s Chief Financial Officer, Roger F. Millay, pursuant to Rule 13a-14 of the Securities Exchange Act of 1934.*
  32.1    Certification of the Registrant’s Chief Executive Officer, John J. Haley, and Chief Financial Officer, Roger F. Millay, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101    The following materials from Towers Watson & Co.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, formatted in XBRL (eXtensible Business Reporting Language); (i) Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2013 and 2012, (ii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended March 31, 2013 and 2012,(iii) Condensed Consolidated Balance Sheets at March 31, 2013 and June 30, 2012, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2013 and 2012, (v) Condensed Consolidated Statement of Changes in Stockholders’ Equity for the nine months ended March 31, 2013, and (vi) Notes to Condensed Consolidated Financial Statements***.

 

* Filed or furnished herewith.
** Designates management contracts and compensation plans.
*** Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

43


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Towers Watson & Co.    
(Registrant)    

/s/ John J. Haley

    May 7, 2013
Name:   John J. Haley     Date
Title:   Chief Executive Officer    

/s/ Roger F. Millay

    May 7, 2013
Name:   Roger F. Millay     Date
Title:   Chief Financial Officer    

/s/ Michael M. Thomson

    May 7, 2013
Name:   Michael M. Thomson     Date
Title:   Controller (Chief Accounting Officer)    

 

44